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Abstract 
Oxidants have long been implicated in the pathogenesis of various kinds of 
cardiovascular diseases (CVD) such as atherosclerosis, ischemia-reperfusion injury and 
hypertension. Atherosclerosis is a chronic and inflammatory disease involving the attack 
of lipids and lipoproteins by reactive oxygen species (ROS). The phagocytosis of the 
oxidized low-density lipoproteins (LDL) by macrophages results in foam cell formation 
in arteries which leads to the development of atheromatous plaque. 
The intake in diet of anti-oxidant compounds or compounds that can reinforce the 
antioxidant power can be considered to be able to prevent the oxidative-related disorders. 
In China, roots of Salvia miltiorrhiza (Danshen) and Puemria lobata (Gegen) are two 
commonly used herbs to possess putative cardioprotective and anti-atherosclerotic effect. 
Previous studies have revealed that the herbal preparation containing both Danshen and 
Gegen in a ratio of 7:3 have good antioxidant ability and vasodilation effect. 
In the present study, Danshen-Gegen compound formula (DG) was investigated from a 
perspective as dietary supplement to reinforce the antioxidant power, to a certain extent, 
for preventing the development of CVD. By an in vitro assay, the ability of DG in 
inhibiting the uptake of acetylated LDL by macrophages was assessed. For in vivo model, 
DG was applied intra-gastrically to young-adult and middle-aged Wistar rats for twelve 
weeks. Plasma was collected to monitor the levels of some major antioxidants and ROS 
detoxification enzymes. After twelve weeks, all rats were terminated and organs were 
isolated for determining the protein expression of the antioxidant enzymes and lipid 
peroxidation level. 
The in vitro assay demonstrated that DG at concentrations above 0.8 mg/ml could inhibit 
foam cell formation from peritoneal macrophages. Besides, the in vivo study of DG on 
young-adult Wistar rats (3-month-old) up-regulated the plasma total antioxidant level, 
superoxide dismutase (SOD), catalase (CAT), glutathione-peroxidase (GPx) activities and 
the vitamin E content in the collected plasma significantly (/7<0.05). In addition, in the 
DG treatment groups, SOD expression in the liver and heart, and catalase expression in 
the brain and heart was found to have a prominent increase. With advanced-age being a 
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high risk factor for CVD, a comparable result was also obtained for the DG treatment in 
middle-aged rats (10-month-old). A significant inhibition (/?<0.05) of lipid peroxidation 
by DG treatment was shown in this group of rats probably due to the higher basal level of 
lipid peroxidation in older rats. 
In conclusion, Danshen-Gegen compound formula could inhibit foam cells formation in 
vitro and up-regulate the antioxidant level in vivo. These indicated that DG can prevent 
CVD development and may be developed as a potential dietary supplement for 
prevention of the disease. 
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摘要 
氧化劑對多種心血管疾病的發病有著重要的角色，如粥樣硬化、心臟缺血及高血壓 
等。血管粥樣硬化是一種慢性、炎症性的疾病，發病的源頭在於過高的活性氧水平 
對細胞和基因結構造成的損壞，巨•細胞對氧化低密度脂蛋白的吞職作用會使動脈 
內形成泡沫細胞，引致動脈硬化班塊的出現。 
飲食中的抗氧化物能預防心血管疾病的發展。丹參和葛根兩種草本藥品在中國長久 
以來用於治療心血管病，並具有保護心血管的作用°較早的硏究顯示七三比例的丹 
參-葛根複方(DG)水提物具有良好的抗氧化及血管舒張作用。 
本研究就丹參-葛根複方能否用作抗氧化補充劑及有效預防心血管疾病的發展進行 
硏究。硏究中用試管實驗的方法，測試複方對巨噬細胞吞職氧化低密度脂蛋白變成 
泡沫細胞的抑制作用，另外，對複方在大鼠的抗氧化系統的作用亦作了評估。年青 
及中年大鼠分別被餓食丹參-葛根複方水提物十二個星期，期間牠們的血獎會被抽 
取，用於監察主要抗氧化物的變化。十二個星期後，大鼠的器官被分隔了出來用以 
量度抗氧化物的蛋白質體表現及脂質過氧化作用的水平。 
試管實驗顯示，劑量大於0.8 mg/ml的丹參-葛根複方對泡沬細胞的形成能起顯著的 
抑制作用。在大鼠實驗中’丹參-葛根複方能提高年青大鼠血漿的總抗氧化能力、 
超氧歧化酵素(SOD)�過氧化氫酶(CAT)�谷腕甘肽過氧化物酶(GPx)活性及維他命 
E含量。此外 ’ S O D在肝臟及心臟� C A T在腦及心臟、以及G P x在肝臟的蛋白質 
體表現皆有明顯提升 (P値<0.05)�年老是心血管疾病發病的其中一個高危因素，丹 
參-葛根複方對中年大鼠的影響與對年青大鼠的影響相若。而且，複方對中年大鼠 
的脂質過氧化作用的抑制作用比在年青大鼠更爲明顯，這可能是由於中年大鼠較高 
的脂質過氧化作用的基準水平。 
總括而言，丹參-葛根複方能抑制泡沫細胞的形成及提高大鼠體內抗氧化物，意味 
將來有機會被發展爲食物補充劑以預防心血管疾病。 
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Chapter 1 INTRODUCTION 
1.1 Atherosclerosis 
1.2 Cardiovascular Disease (CVD) 
1.3 Reactive Oxygen Species (ROS) 
1.4 Antioxidants 
1.5 Ageing 
1.6 Antioxidants and CVD 
1.7 Traditional Chinese Medicine (TCM) 
1.8 Aim of Study 
Cardiovascular disease is the leading cause of mortality in the world especially in 
developed countries. The prime cause is atherosclerosis. Many studies support a 
critical role of oxidative stress not only in the normal functioning of cardiac and 
vascular cells, but also in the pathogenesis of the vascular disease. More and more 
studies focus on the critical roles of reactive oxygen species (ROS) on the 
development of the chronic and fatal disease. 
1.1 Atherosclerosis 
Atherosclerosis is a chronic, cumulative and degenerative disease that affects the 
arteries. Arteries consist of three layers. The innermost layer that is in direct contact 
with the blood flow is called the tunica intima. This layer is made up of mainly 
endothelial cells. The middle layer is the tunica media. It is made up of smooth 
muscle cells and elastic tissue. The outermost layer is the tunica adventitia. This 
layer is composed of connective tissue. 
Atherosclerosis is commonly referred to the "hardening" of arteries due to the 
development of an atheromatous plaque. Atherosclerosis is a body wide process 
which can occur in the arteries to, for example, the heart, brain and legs. The 
blockage of the artery would lead to myocardial infarction, stroke and claudication, 
respectively. The pathogenesis of atherosclerosis involves endothelium dysfunction, 
infiltration of monocytes, differentiation of monocytes to macrophages, foam cells 
formation, smooth muscle cell proliferation (Ross, 1993) and even calcification at the 
vessel wall at later stage. 
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1.1.1 Pathogenesis of Atherosclerosis 
Endothelium dysfunction 
Vascular endothelium is important in maintaining cardiovascular homeostasis. 
Endothelium serves as a selective gate that permits the transport of glucose, nutrients, 
metabolites and hormones from blood to tissues and vice versa. On the other hand, it 
serves as a mutual barrier against the infiltration of low-density lipoprotein (LDL) 
from the bloodstream into the vessel wall. Normal functions also include the release 
of nitric oxide, which is an important vasorelaxing factor. Nitric oxide modulates 
vascular tone and inhibits platelet adherence and aggregation, endothelial cell-
leukocyte interaction and smooth muscle proliferation (Villalobo, 2006). 
Endothelial dysfunction is resulted from the exposure to a "toxic" environment such 
as increased oxidative stress. Many of the cardiovascular risk factors are associated 
with overproduction of reactive oxygen species, such as hyperlipidemia, 
hypertension, diabetes and smoking. Endothelial dysfunction leads to the loss of 
nitric oxide bioactivity which in turn leads to abnormal vasodilatory response, 
increased production of vasoconstrictor substances, impaired endothelial control of 
inflammation and thrombosis, and altered expression of adhesion molecules. Hence, 
oxidative stress is considered to be involved in the pathogenesis of endothelial cells 
dysfunction (Tomasian et al., 2000). 
Infiltration of LDL and monocytes 
Endothelial dysfunction allows the entry and deposition of circulating LDL in the 
intima. Each LDL particle contains an apolipoprotein B-lOO molecule that makes 
them soluble in the aqueous environment. As cholesterol and triglycerides are 
relatively insoluble in water, LDL is responsible for the transportation of cholesterol 
and triglycerides from the liver and small intestine to cells and tissues. LDLs 
transport cholesterol to the arteries and can be retained there by arterial 
proteoglycans. This initiates the formation of plaques when it invades the 
endothelium. Therefore, LDL is often regarded as bad cholesterol because high LDL 
level is often associated with atherosclerosis, and thus cardiovascular disease. The 
oxidation of LDL is stimulated by ROS and the oxidized form is more easily retained 
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by the proteoglycans. 
Studies have revealed that oxidized low density lipoprotein (oxLDL) plays an 
important role in the initiation and progression of atherosclerosis. The oxidation of 
lipoproteins can occur locally in the arterial wall or the circulating oxidized 
lipoproteins can deposit in the atherosclerotic lesions (Steinberg, 1997). Oxidized 
LDL can increase leukocyte recruitment and activation by inducing endothelium to 
produce intracellular adhesion molecule-1 (ICAM-1), vascular cell adhesion 
molecule-1 (VCAM-1) and E-selectin, which promote leukocyte adhesion onto the 
arterial wall. It also stimulates the production of monocyte chemo attract ant protein 
(MCP-1) and cytokines. The adhered leucocytes can transmigrate into the intima. 
Monocytes differentiate into macrophages. 
Foam cells formation 
LDL, especially in the oxidized form, is taken up by scavenger receptors of 
macrophages by phagocytosis (Fig 1.1). The LDL is then hydrolyzed to release free 
cholesterol and fatty acids. The conversion of free cholesterol to cholesteryl esters is 
catalyzed by the enzyme acyl-Co A: cholesterol acyltransferase (ACAT) using 
cholesterol and long-chain fatty acylcoenzyme A as substrate (Chang et al., 1997). 
Two isoforms have been revealed: ACAT-1 and ACAT-2. ACAT-l is the major 
isoform that can be found in macrophages and also in liver (Chang et ai, 2001). The 
imbalance of the lipoprotein uptake and the cholesterol efflux would lead to the 
build-up of cholesteryl esters inside the macrophages and thus foam cells formation. 
Foam cell is characterized with its bigger size and high lipid content. As foam cells 
die and leads to further formation of foam cells, this can grow into a fatty streak and 
finally develop into atheromatous plaque (Parthasarathy et ai, 1986). 
In vitro foam cells formation can be produced by treating macrophages with 
acetylated LDL (acLDL) (Brown and Goldstein, 1983). This gives a simple 
pathophysiological model for the early-stage development of atherosclerosis. Hence, 
the efficiency of anti-atherosclerotic drug can be evaluated. 
Smooth muscle cell proliferation & calcification 
Stimulated by foam cells' secretion of cytokines and growth factors, smooth muscle 
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cells migrate from the media into the intima where they proliferate and produce 
connective tissue. Deposition of collagen and foam cells result in a protective fibrous 
cap formation at the intima. Also, intracellular calcification in the surrounding 
smooth muscle cells leads to extracellular calcium deposits between the media and 
outer portion of the atheromatous plaques. 
Adhesion Vascular 
vcAMi lumen 
Monocyte 
: 〇 l d l 一 z 凑 少 
1 . m ^ e n J m J ^ L D l ^ l T 丨�n A 
一 — M V 、 ， ^rW^ 
Fig 1.1 Foam cell formation, initiation of a fatty streak lesion. (Glass and Witztum, 
2001) 
1.1.2 Atherosclerosis and Cardiovascular Disease 
Atherosclerosis starts with the deposition of lipoproteins in the arterial wall. An 
early-stage plaque can be compensated for by artery enlargement. But the ever 
growing plaque finally leads to the narrowing of the lumen of the artery (stenosis) 
and causes a reduction in blood supply to the organs. Furthermore, the plaque is 
rather vulnerable. Under the inflammatory response to stop the blood flow, its 
rupture leads to the formation of a blood clot (thrombus). This clot can block the 
artery and stop the blood supply. The downstream tissues would become starved of 
oxygen and nutrients. This can be fatal if the blocked artery leads to a vital organ, e.g. 
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insufficient blood supply to the myocardium would result in angina or myocardial 
infarction. Thus, cardiovascular disease is resulted. 
Early stage of atherosclerosis is asymptomatic and difficult to be detected by most 
diagnostic methods. The current diagnostic techniques, angiography and "stress 
testing" only manage to detect severe narrowing, not the underlying atherosclerosis 
disease. As an atheromatous plaque grows slowly and raises awareness only when 
the situation becomes severe enough to restrict blood supply to certain vital organs 
that brings about symptoms, e.g. angina, prevention measures of the disease is 
essential. 
1.2 Cardiovascular Disease (CVD) 
Atherosclerosis leads to the narrowing of arteries and reduced blood supply to distal 
and peripheral organs, and is associated with the development of cardiovascular 
disease (CVD). CVD is the leading cause of death in the world especially in the 
developed countries. In the United States, in every year since 1900, except 1918, 
CVD accounted for 36.3% of all deaths in 2004. CVD claims more lives each year 
than the combined number of cancer, chronic lower respiratory diseases, accidents 
and diabetes mellitus fMinino et ai, 2006). According to the Census and Statistics 
Department (2005), diseases of heart are the second leading cause of mortality which 
accounted for 86.1 deaths per 100,000 populations in Hong Kong. 
1.2.1 Term Definition 
CVD is a family of diseases related to the diseases of heart and the circulatory 
system. Different terms have been used in different surveys concerning the disease. 
"Total cardiovascular disease" includes diseases of heart, diseases of the circulatory 
system and congenital cardiovascular defects (American Heart Association, 2007). 
"Diseases of heart" includes acute rheumatic fever/ chronic rheumatic heart disease, 
hypertensive heart disease and hypertensive heart and renal disease, coronary heart 
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disease, pulmonary heart disease and diseases of pulmonary circulation, heart failure, 
and other forms of heart disease. "Diseases of the heart" represents about three-
fourths of the "total cardiovascular disease" mortality; 
“Diseases of the circulatory system" includes cerebrovascular disease (stroke), 
atherosclerosis, other diseases of arteries, arterioles and capillaries, diseases of veins, 
lymphatics and lymph nodes not classified elsewhere, and other unspecified 
disorders of the circulatory system, 
"Coronary Heart Disease" (CHD) is a common type of CVD and is included as a part 
of "diseases of heart". It includes acute myocardial infarction (MI or heart attack), 
other acute ischemic (coronary) heart disease, angina pectoris (chest pain or 
discomfort that's unexpected and usually occurs while at rest), atherosclerotic 
cardiovascular disease, and all other forms of chronic ischemic heart disease. 
If all forms of major CVD were eliminated, life expectancy would rise by almost 
seven years (National Center for Health Statistics, 1999). 
Vascular injury accumulates from adolescence and the atheromatous plaque grows 
slowly, prevention efforts should begin as soon as childhood. By the time that 
symptoms appear and heart problems are detected, atherosclerosis usually has 
reached an advanced stage. Fifty percent of men and 64% of women who died 
suddenly of CHD had no previous symptoms of this disease (Hurst, 2002). There is, 
therefore, increased emphasis on the prevention of the disease. 
1.2.2 Risk Factors 
A number of high risk factors for CVD have been identified. These include 1) 
advanced age; 2) male gender; 3) heredity; 4) physical inactivity (fail to meet the 
recommended levels of physical activity which is light-moderate activity for >30 min 
with >5 times per week; or vigorous activity for >20 min with >3 times per week); 5) 
tobacco smoking, 6) having diabetes mellitus; 7) high blood cholesterol and other 
lipids (the fasting LDL-cholesterol level larger than 3.3 mmol/L); 8) overweight and 
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obesity, and 9) elevated serum level of homocysteine. 
1.2.3 Current Western Medications 
The financial burden in the treatment of CVD is heavy; yet, different western 
medications are incapable of curing CVD completely. The cost of cardiovascular 
diseases and stroke in the United States for 2007 is estimated at $431.8 billion. By 
comparison, in 2004 the estimated cost of all cancers was $190 billion. 
Drugs 
The current western medication in the treatment of CVD includes aspirin, statin, 
ACE inhibitor, diuretics, beta blockers and folic acid. However, medicines are 
criticized for their expense, patented control and occasional undesired side effects, 
especially for their long term administration. For example, anti-coagulating aspirin is 
dangerous for pregnant women, and can induce gastrointestinal bleeding, nausea, 
vomiting, ulcers and rash. Overdose poisoning even leads to death. The most 
common adverse effect of statins is muscle problems which can lead to kidney 
failure. Also, gastrointestinal problem, shortness of breath, cognitive loss, rash and 
skin problem and sleep problems are widely reported. Blood pressure-lowering ACE 
inhibitor can lead to cough, headache, and dizziness; whereas diuretics can cause 
electrolyte defects and/or metabolic abnormalities and occurrences (Sica, 2004). Beta 
blockers slow heart rate and are used to treat high blood pressure. But the side effects 
include cold hands and feet, tiredness and sleep disturbance. Folic acid decreases 
homocysteine level which is associated with cardiovascular disease. But it may 
prolong diarrhea, mask vitamin B12 deficiency and interfere with zinc absorption in 
the intestine (Milne et a/., 1984). 
Medical Procedures 
Other physical treatments like angioplasty and bypass surgery are, apart from their 
high cost and invasive procedures, only helpful in short term. They are used to 
physically expand narrowed arteries or to create additional blood supply connections 
which go around the more severely narrowed areas. It has been reported that the 
recurrence rate for the patients with coronary in-stent restenosis (ISR) having had 
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cutting balloon angioplasty (CBA) was about 29.8% (Albiero et al., 2004). Although 
aerobic exercises, weight loss and dietary change can also help, they are less 
effective due to the difficulties for many to continue in long term. 
Despite the medical treatments that focus on relieving the symptoms resulting from 
atherosclerosis, the more effective implication should be the preventive measures on 
decreasing the underlying cause of atherosclerosis. In this aspect, improving the 
antioxidant system may be the key. 
1.3 Reactive Oxygen Species (ROS) 
Oxidants, or reactive oxygen species (ROS) and reactive nitrogen species (RNS), 
have long been implicated in the pathogenesis of various kinds of atherosclerosis and 
thus cardiovascular diseases (CVD). The type of reaction ROS and RNS are engaged 
in is called a reduction-oxidation (redox) reaction. Oxygen is essential for respiration 
and other oxidative reactions in aerobic metabolism in organisms. During the 
reduction of molecular oxygen, ROS, including free radicals, may be formed. A free 
radical is any atom or molecule that contains one or more unpaired electrons 
(Anderson and Phillips, 1999) which usually make the radical more reactive than the 
corresponding atom or molecule. ROS can also lead to increased production of free 
radicals from lipid peroxides. Reports have shown that these reactive species are 
associated with many oxidative related disorders including atherosclerosis (Witzum, 
1994), respiratory tract disorders (Cross et al., 1994), neurodegenerative diseases like 
dementia and Parkinson's disease, cancer (Chow, 2001) and ageing (Ames, 1989). 
1.3.1 Impact of ROS 
Although ROS is traditionally regarded as a harmful byproduct of the aerobic 
metabolism, it should be the intracellular level of ROS that is crucial in determining 
the cell's final fate. They are involved in the inflammatory response and act as 
intracellular signaling molecules, regulating differentiation, proliferation, or 
apoptosis. Therefore, it contributes in the defense mechanisms against the invading 
microorganisms and malignant cells. Low concentration of H2O2 has been shown to 
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induce mitosis in fibroblasts, while relatively higher concentrations would cause a 
transient cell growth arrest (Crawford et aL, 1996). And further higher 
concentrations would damage the cells by the combined effect of apoptosis and 
necrosis (Davies, 2000). 
Oxidative stress is resulted when there is an imbalance between the excessive 
formation of ROS and insufficient antioxidant level. If the extra ROS are not 
eliminated by antioxidants, they can attack and alter the structure and function of 
several biological molecules, such as cell membrane, lipoproteins, lipids, proteins, 
carbohydrates, RNA, and DNA (Biomhoff, 2005). Lipids and lipoproteins are 
particularly susceptible because the hydrogen abstraction initiates a chain reaction, 
i.e. lipid peroxidation, which is widely reported to be involved in atherosclerosis 
development (Witzum, 1994). In the pathogenesis of atherosclerosis, ROS contribute 
to endothelial dysfunction, LDL oxidation, local MCP-1 production, upregulation of 
adhesion molecules and thus monocytes recruitment, extracellular matrix remodeling 
through collagen degradation and eventually plaque rupture (Griendling et al 2000). 
ROS usually have short half life of only seconds. However, the ROS-modified lipids, 
proteins, carbohydrates and nucleic acid can last from hours to weeks (Pryor, 1986). 
1.3.2 Superoxide Anion Radical, Hydrogen Peroxide, Hydroxy 1 Radical, Nitric 
Oxide 
Superoxide anion radical (CV—) is produced from several different oxidase enzymes 
and autoxidation reactions within the body by the addition of an electron to an 
oxygen molecule. For example, potential sources of vascular superoxide production 
include NAD(P)H-dependent oxidases, xanthine oxidase, lipoxygenase, 
mitochondrial oxidases and NO synthases (Channon and Guzik, 2002). 
Lymphocytes including neutrophils, eosinophils, monocytes and macrophages 
produce superoxide radicals as part of their immune response against pathogens. 
Increase in superoxide radicals would lead to disruption of cell membrane and 
cellular dysfunction. 
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Although superoxide is not highly reactive, it can cause the formation of other more 
reactive species. Two superoxide radicals can lead to the formation a hydrogen 
peroxide ( H 2 O 2 ) . H2O2 can react with reduced metal ions, e.g. Cu^^ and Fe^^, and 
give rise to OH" and the highly damaging OH.. Superoxide radicals can further 
contribute by reducing the oxidized metal ions. The in vitro model of oxidative 
damage leading to cytotoxicity and genotoxicity, implicated as well as in 
ischaemia/reperfusion injury, has demonstrated that H2O2 is the central cause 
(Anderson and Phillips, 1999). Hydroxyl radical OH- is highly reactive and leads to 
cell membrane lipid degradation. It is also produced from water by ionizing radiation. 
Nitric oxide (NO.) is produced by nitric oxide synthase (NOs) using L-arginine in 
vascular endothelium to act as a relaxing factor in vascular smooth muscle. It 
decreases vascular resistance and blood pressure. Thus, endothelium plays an 
important role on the relaxation of arteries. On the other hand, nitric oxide is also 
produced by phagocytes (Moncada and Higgs, 1993). Besides, NO- inhibits platelet 
adherence and aggregation, endothelial cell-leukocyte interaction and smooth muscle 
proliferation (Villalobo, 2006). Loss of NO- bioactivity plays an important role in 
vascular disease pathogenesis. One of the mechanisms accounting for NO. deficient 
is increased ROS level that it reacts with superoxide radical The half-life of N O is a 
few seconds only. It can be degraded by superoxide to produce peroxynitrite by the 
following reaction: 
O2.-+NO—ONOO.-
Peroxynitrite can decompose into OH., nitrogen dioxide and nitronium ion (N02+). 
Moreover, peroxynitrite has additional detrimental effects on vascular function. 
These include oxidation of cellular proteins and lipids, LDL particles (White et al,, 
1994), or direct cell toxicity (Ballinger et al” 2000). The reaction between NO- and 
superoxide occurs at rate that is almost six times greater than the removal of 
superoxide by copper-zinc superoxide dismutase (Cu/Zn SOD) (Channon and Guzik, 
2002). Thus, larger oxidative stress leads to quicker degradation of N O and the 
reduced bioavailability of N O in turn results in hypertension progression. 
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1.3.3 ROS Production by NAD(P)H Oxidases 
Xanthine oxidase was previously identified as the prime source of O2 " production. 
Recently, NAD(P)H oxidases have been established as critical determinants of the 
redox state in vascular and cardiac tissues. 
NAD(P)H oxidases are an important source of superoxide production in the human 
vessels (Griendling, 2000) and myocytes especially in atherosclerotic coronary 
arteries (Sorescu et a/_, 2002), in saphenous veins and mammary arteries from 
patients having coronary artery disease (Guzik et ai, 2002), in human vascular 
smooth muscle cells (Touyz et al., 2002) and endothelial cells (Rueckschloss et al., 
2001) in culture. 
NAD(P)H oxidases are membrane-associated enzymes which span the membrane, 
utilize intracellular NADH or NADPH and transfer electrons across the membrane to 
extracellular oxygen. It is important in the ROS production in immune cells. Upon 
activation, neutropils, monocytes and macrophages increase their O2 consumption, 
known as the respiratory burst, and produce O2 " and subsequent H2O2 and OH- for 
combating the stimuli. The NAD(P)H oxidases catalyze the 1 -electron reduction of 
oxygen using NADH or NADPH as the electron donor. 
NAD(P)H + 2O2 — NAD(P)+ + H+ + lOr 
NADPH and NADH are equally good substrates in vascular smooth muscle cells 
(VSMC) while NADH-driven CV production predominates in endothelial cells (ECs) 
(Griendling et al., 2000). The cardiovascular NAD(P)H oxidases possess lower 
activity rate, thus release O2 ' more slowly than those of the neutrophil NAD(P)H 
oxidase. Capacity of O2 " production in neutrophils was estimated to be three-fold 
higher than that of the vascular cells (Griendling and Ushio-Fukai, 1998). The O2 ' 
release from neutrophils is almost instantaneous while O2 " produced in ECs, VSMCs 
take minutes to hours (Ohara et al., 1993). 
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Fig 1.2 Structure of the NAD(P)H oxidase. Left, Functional structure of the 
neutrophil NAD(P)H oxidase. Right, Components of the neutrophil oxidase that have 
been identified in VSMCs. (Griendling et al., 2000) 
1.3.4 ROS Production by Mitochondria 
Mitochondria are the major site of ROS production and ROS-induced injury. 
It is the "power plants" in cells for ATP synthesis to maintain normal cellular activity, 
body function and metabolism. In normal aerobic metabolism, oxygen is converted 
to water at the end. The mitochondrial electron transport chain (mtETC) locates at the 
inner membrane of a mitochondrion. Electrons in the mtETC are transferred from 
ubiquinone to a terminal oxidase, either cytochrome c oxidase (COX) or cyanide-
insensitive alternative oxidase (AOX) (Finnegan et al., 2004), where oxygen is 
reduced to water. However, in this electron transport chain, oxygen is "partially 
reduced" to form superoxide radical. The production of superoxide by the 
mitochondrial respiratory chain occurs continuously during normal aerobic 
metabolism. Superoxide is then converted to H2O2. It possesses relatively lower 
toxicity but can react with reduced Fe^ "^  and Cu^^ to produce the highly toxic 
hydroxyl radicals. Also, being uncharged, H2O2 can penetrate membranes and leave 
the mitochondrion (Sweetlove and Foyer, 2004). 
Endogenous signaling molecule nitric oxide (NO.) is an inhibitor of COX, but not 
AOX (Millar and Day, 1996). Therefore, NO- production could lead to increased 
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ROS formation by mitochondria. 
Functions of mitochondria in macrophages are active (You and Lin, 2002). When 
leukocytes encounter microorganisms or other pathogens, which can trigger our 
immune system, invading our bodies, they start to generate large amount of 
superoxide. 
1.3.5 Lipid Peroxidation 
Oxidative stress due to the lipid peroxidation products is particularly more damaging 
because lipid peroxidation leads to a facile propagation of free radical reactions. 
Lipid peroxidation is a chain reaction involved in the oxidative degradation of lipids. 
Similar to other chain reaction, the reaction consists of three major steps: initiation, 
propagation and termination. 
Lipid peroxidation is initiated with the production of a lipid radical (L.). The 
initiators in living cells are usually ROS, such as OH., which combines with a 
hydrogen atom from the polyunsaturated fatty acid (PUFA) moiety of membrane 
phospholipids to make water and a lipid radical. 
The lipid radical may rearrange to a more stable conjugated diene. And it reacts 
readily with an oxygen molecule, thereby creating a lipid peroxyl radical (LOO ). 
This is also an unstable species that can propagate the chain reaction. It reacts with 
another free fatty acid to produce a different lipid radical and a lipid hydroperoxide 
(LOOH) or cyclic peroxide if it had reacted with itself. Phospholipid hydroperoxides 
(PL-OOH) and fatty acid hydroperoxides (FA-OOH) are the major constituents of 
the LOOH. The fatty acid carbon chain may also be spontaneously cleaved ((3-
scission) during lipid peroxidation, yielding a variety of highly reactive compounds, 
including pentane and ethane radicals, and the a, ^-unsaturated aldehydes (Yang et 
fl/., 2003).This cycle continues as the new lipid radical reacts in the same way. 
Lipid peroxidation is highly damaging because a radical reacts and give rise to 
another radical. A possible way to stop the reaction is for two radicals to react and 
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produce a non-radical species. This is confined to a condition when the concentration 
of radical species is high enough for two radicals to collide. Living organisms have 
evolved different defense mechanisms that catch free radicals and protect the cell 
membrane. Low molecular mass compounds, known as the "chain-breaking 
antioxidants", can scavenge peroxyl radicals and provide first line of defense against 
lipid peroxidation. These compounds can interrupt and terminate the propagation of 
the chain reaction. The main cellular chain-breaking antioxidants include a-
tocopherol (vitamin E), ascorbic acid (vitamin C), glutathione (GSH), uric acid, 
carotenoids, ubiquinone, and polyphenols (Acworth et al., 1997). 
The antioxidant enzymes involved in the second line of defense can impose both 
primary and secondary actions against oxidative stress. The primary action is the 
preventive measure which decomposes ROS and prevents initiation of lipid 
peroxidation. These enzymes include superoxide dismuatase (SOD), catalase (CAT), 
and glutathione peroxidase (GPx). The secondary action involves excision or 
repairment of any lesions caused by ROS. In lipid peroxidation, secondary defense 
enzymes are involved in the removal of LOOH to prevent the propagation of the 
auto catalytic reaction. GPx and GST which catalyze GSH-dependent reduction of 
LOOH (PL-OOH and FA-OOH) through their peroxidase activity are the major 
secondary defense to guard against ROS-induced lipid peroxidation. Among the four 
selenium-dependent GPx isoenzymes, GPx-1, GPx-2, and GPx-3 are involved in the 
reduction of H2O2 and FA-OOH, whereas GPx-4 displays activity towards PL-OOH 
and cholesterol hydroperoxides (Thomas et al., 1990). These enzymes protect 
membrane integrity. 
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Fig 1.3 Chain reaction of lipid peroxidation. 
1.3.6 Other Sources of ROS 
ROS plays an important role in generating oxidized lipoproteins. Apart from normal 
cellular metabolic reactions, the reactive molecules also come from some external 
sources of superoxide, especially cigarette smoke, which is "packed" with free 
radicals and ROS. Also, biotransformation of various xenobiotics and drugs, UV and 
ionic irradiation (Griendling et al., 2000) lead to ROS formation (Ames et al., 1993). 
Additionally, natural food constituents, oxidized lipids or fatty acids, in the diet are 
absorbed and incorporated into the serum lipoproteins. They are then transported to 
the liver and secreted into the circulation via very low density lipoproteins (VLDLs) 
(Staprans et al., 1996). Similarly, oxidized dietary cholesterol can be incorporated 
into the serum lipoproteins. 
ROS impose oxidative stress on the endothelium and may cause cell injury. This 
would intensify hypertension. It is suggested that oxidative stress should be 
considered a potentially important source of patient morbidity and mortality 
(Locatelli et al., 2003). 
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1.4 Antioxidants 
Our bodies have developed the antioxidant system to counteract excess ROS or to 
limit the ROS level and the damage they impose. An antioxidant can be defined as a 
substance that, when present at a relatively low concentration, can significantly 
prevent or delay a pro-oxidant to initiate an oxidation reaction. It reduces a pro-
oxidant by turning it into products having no or low toxicity (Prior and Cao, 1999). 
Antioxidants form a network because the antioxidant that reacted with ROS is often 
transformed into an 'antioxidant radical'. Although the resulting radical has a lower 
activity to react with vital cellular targets, it can still cause damage (Buettner, 1993). 
It needs to be reacted with another antioxidant to bring the reactivity further down. 
These reactions continue in a stepwise fashion, involving a number of antioxidant 
molecules, until the product is no longer threatening (Blomhoff, 2005). 
The antioxidant system consists of macro-molecules, e.g. antioxidative enzymes like 
superoxide dismutase, catalase and glutathione peroxidase, and micro-molecules or 
nonenzymatic antioxidants, such as vitamins, GSH, uric acid, flavonoids, and 
bilirubin. They prevent radical formation, remove radicals before damage can occur, 
repair oxidative damage, eliminate damaged molecules, and prevent mutations. In 
addition, detoxification enzymes, such as the glutathione S-transferase family, g-
glutamyl cysteine synthetase and NAD(P)H : quinone reductase, are also essential 
members in antioxidant system. These enzymes are generally regarded as phase 2 
enzymes because they catalyze the conversion of toxic metabolites to compounds 
that are more readily excreted (Blomhoff, 2005). 
1.4.1 Superoxide Dismutase (SOD) 
Superoxide dismutase (SOD) is one of the most important antioxidative enzymes as 
it is the first line of antioxidant defense. It has the fastest reaction rate with its 
substrate among any other known enzymes. It converts superoxide radicals to a less 
reactive H2O2. 
202- + 2H+~>H202 + 02 
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The term "dismutation" is used to describe a chemical reaction in which an element 
is simultaneously reduced and oxidized to form two different products. In this case, 
SOD catalyzes the dismutation of Or' into O2 and H2O2. There are several common 
forms of SOD having different metal ion cofactors, for example, copper and zinc, 
manganese, iron, or nickel. The copper and zinc form (Cu-Zn-SOD) locates at the 
cytosol of virtually all eukaryotic cells. The Mn-SOD can be found in mitochondria 
and many bacteria, such as E. coli. Some bacteria also contain the iron form (Fe-
SOD). In humans, three forms of SOD are present. SODl is a dimer and can be 
found in the cytoplasm. S0D2 is in the mitochondria and SOD3 is extracellular. 
They are tetramers. SODl and SODS are Cu-Zn-SOD, whereas SOD2 is Mn-SOD. 
1.4.2 Catalase (CAT) 
Catalase is a tetramer present in most aerobic cells. A heme group with an iron centre 
is attached to the enzyme. It converts two molecules of H2O2 to molecular oxygen 
and two molecules of water. In human, catalase can be found in every organ. It is 
particularly abundant in liver, kidney and erythrocytes, where the majority of 
hydrogen peroxide decomposition is carried out. 
2H2O2 — 02 + 2H2O 
1.4.3 Glutathinoe Peroxidase (GPx) 
Glutathione peroxidase (GPx) catalyzes the reduction of lipid hydroperoxides into 
alcohols by oxidizing glutathione (GSH). Therefore, it decreases lipid peroxidation, 
protects membrane integrity and thus prevents cell damage. GPx also breaks down 
H2O2 into O2 and water. Several selenium-dependent GPx isoforms have been 
characterized in mammalian tissues (Awasthi et al., 1975; Chu et al., 1993; 
Takahashi et al” 1987; Ursini et aL, 1985). The cytosolic/mitochondrial GPx-1 was 
the first to be discovered. GPx-2 expresses in the epithelium of gastrointestinal tract. 
GPx-3 expresses mainly in the kidney and is released into blood. GPx-4 expresses in 
most tissues and can reduce hydroperoxides in membranes and hydroperoxylipids. 
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GPx-1, GPx-2, and GPx-3 are involved in the reduction of H2O2 and FA-OOH, 
whereas GPx-4 displays activity towards PL-OOH and cholesterol hydroperoxides 
(Thomas et al., 1990) (detail for lipid peroxidation in section 1.3.5). Except for GPx-
4, all of the GPx are tetramers consisting of four identical subunits. Excluding the 
Cys containing GPx-3 and epididymis specific secretory GPx-5, each subunit 
contains a selenocysteine at the active site which participates in the reduction of the 
substrate, i.e. LOOH. The enzyme then regenerates the reduced form of 
selenocysteine at the expense of the electron donor, GSH. 
LOOH + 2GSH ROH + GSSG + H2O 
1.4.4 Glutathione-S-Transferase (GST) 
The a-class GSTs play a key role in regulating lipid peroxidation by terminating the 
autocatalytic chain of lipid peroxidation (Yang et al., 2003). It catalyzes the 
conjugation of GSH to electrophilic sites of the toxicant to make them more water-
soluble for excretion. GSTs use organic hydroperoxides such as cumene 
hydroperoxide (CU-OOH) and tert-buty\ hydroperoxide (t-BHP) as the substrates. In 
addition to GPx, the selenium-independent a-class GST in human is also involved in 
the reduction of LOOH, for both FA-OOH and PL-OOH. GSTs isolated from rat skin 
catalyze the reduction of cholesterol hydroperoxides (Hiratsuka et al., 1997). 
1.4.5 Vitamin E 
Vitamin E family consists of a, p, y and 6-tocopherols, and a, P, y and 5-tocotrienols 
(Brigelius-Flohe et al., 2002). a-tocopherol is the principal form of vitamin E. 
Among different vitamins, it is the most effective antioxidant in vitro and has the 
highest bio activity in vivo (Brigelius-Flohe and Traber, 1999). Vitamin E is the only 
lipid-soluble, chain-breaking antioxidant in biological membranes. 
It scavenges the intermediate peroxyl radicals and also the mutagenic electrophiles, 
e.g. NOx (Christen et al, 1997) by forming a low-reactivity tocopheroxyl radical. It 
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is important in the protective role against cardiovascular diseases (Muller and Goss-
Sampson, 1990). 
1.4.6 Vitamin C 
Vitamin C is a water-soluble vitamin. At biological pH, the main form of vitamin C 
is ascorbic acid (AA) (Karlsen et al., 2005). It directly scavenges O2' and OH.. Also, 
it prevents the initiation of lipid peroxidation by binding with lipid peroxides such as 
alkoxyl, peroxyl and hydroperoxyl radicals, and reactive nitrogen radicals such as 
nitrogen dioxide, nitroxide and peroxynitrite, and transition metal ions (Carr and Frei, 
1999). It is suggested that water-soluble antioxidants fail to adhere to LDL particles 
and therefore cannot inhibit LDL oxidation in the subendothelial space. However, 
they are effective in preserving the endogenous antioxidants in LDL (Jialal and 
Grundy, 1991). It also regenerates a-tocopherol from its radical form and generates 
the ascorbyl radical (Anderson and Phillips, 1999; Buettner, 1993). Vitamin C in 
respiratory tract scavenges oxidants like NO2", ozone, free radicals in cigarette smoke 
(Slade et al., 1993). But vitamin C can be a pro-oxidant at higher dosages (Lee et al., 
2004). 
1.5 Ageing 
Advanced age is a high risk factor for CVD. In the survey concerning the health 
status of older persons (2005), persons aged over 60 were defined as elderly. For 
those who resided in domestic households, 71.6% reported to have chronic diseases. 
Among them, 55.6% suffered from hypertension, 17.1% had high cholesterol, and 
14.8% had heart diseases. 
According to the Heart Disease and Stroke Statistics (American Heart Association, 
2007), an estimated 80 million American adults (about one third of the total 
population) have one or more types of CVD, in which about 47.2% are estimated to 
be aged 65 or older. 
The average rates of the first major cardiovascular events in men rise from seven per 
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1,000 at ages 35-44 to 68 per 1,000 at ages 85-94. Comparable rates occur in women 
10 years later in life. The gap narrows with advancing age (Hurst, 2002). 
One of the reasons for advance-aged persons being more likely to develop CVD may 
be the consequence of diminished antioxidant protection (Hagihara et ai, 1984). 
Decrease of SOD and GPx has been shown in ageing (Vertechy et al., 1993). The 
measurement of total antioxidant capacity revealed an age-related decrease in non-
enzymatic antioxidant defense which may contribute to endogenous lipid 
peroxidation (Zhang et al., 2003). Decreased catalase activity has been shown in old 
animals compared to adult ones. Ageing has been shown to increase the sensitivity of 
the myocardium to ischaemia and reperfusion. It is suggested that reinforcement of 
the myocardial antioxidant system may prevent this increased sensitivity in the 
elderly (Tanguy et al., 2003). In addition, many elderly are prone to vitamin 
deficiency. The diet imbalance may be due to chewing problem, taste, poor appetite 
and other age-related medical conditions (Chow, 2001). 
According to the Census and Statistics Department (2007), Hong Kong population is 
ageing. The percentage people in the age group 35-64 rose from 42.3% in 2001 to 
45.3% in 2006. For people above 65 years old, the percentage rose from 11.2% in 
2001 to 12.4% in 2006. CVD is likely to continue to impose a substantial burden on 
health care resources for the next generation. 
Although the mortality benefits of statins on CVD are widely reported on patients 
having high risk of cardiovascular disease, no trend toward survival benefit is seen in 
elderly patients (Shepherd et al, 2002). Moreover, the potential adverse effects 
despite the potential benefits must be emphasized particularly in elderly patients, for 
whom both risks and benefits differ relative to younger patients (Golomb, 2005). A 
less favorable risk-benefit profile may particularly hold for patients older than 85, for 
whom may have higher risk but attenuated benefits (Weverling-Rijnsburger et aL, 
1997). 
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1.6 Antioxidants and CVD 
A diet rich in antioxidants, such as fruits and vegetables, reduces the risk of 
cardiovascular diseases, and most countries have developed recommendations for an 
increased intake of fruit and vegetables. The mechanism and the compounds 
involved in the protective effect are most likely due to the oxidative stress reduction 
by dietary antioxidants (Biomhoff, 2005). 
Antioxidants are proposed to inhibit multiple proatherogenic and prothrombotic 
oxidative events in the artery wall. Antioxidants that can inhibit LDL oxidation may 
interrupt atherosclerosis development (Lusis and Navab, 1993). Therefore, diet rich 
in antioxidants may protect against CHD (Chow, 2001). It has been revealed that 
Vitamin E supplement users has 43% lower risk of CHD than non-users and the risk 
of CHD was inversely related to the duration of supplement (Stamfer et a/., 1993). In 
another study, tocopherol supplement daily was found to reduce the risk of MI and 
all cardiovascular events in patients with angiographic evidence of coronary 
atherosclerosis (Stephen et al., 1996). A cohort study concludes that intake of fruits 
and vegetables, which are rich in antioxidants, may protect against stroke 
development in man (Gillman et al., 1995). 
However, in the Heart Outcomes Prevention Evaluation Study (Yusuf et al., 2000), a 
different result was observed. The study enrolled clients who were at least 55 years 
old and at high risk of cardiovascular events. There was no significant difference 
between vitamin E and placebo group though there was no adverse effect from 
vitamin E in long-term treatment. It concluded that the reason for the above result 
might be the use of vitamin E alone without other antioxidants. In epidemiological 
studies, higher vitamin E intake was associated with lower rates of CHD. But this 
correlation was not definite in the clinical trials. It has been noted that in most of the 
epidemiological studies, dietary vitamin E was taken with other antioxidants and 
micro-nutrients. Vitamin E supplement may require other antioxidants or 
micro nutrients as co factors to produce the beneficial effects (Chow, 2001). 
Although a single antioxidant supplement may not be powerful enough to provide 
significant preventive effect on CVD, a combination of a variety of different 
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antioxidants may be needed to keep the animal cells protected from oxidative stress 
(Biomhoff, 2005). The intake in diet of antioxidant compounds that can reinforce the 
antioxidant system, which consists of many different enzymatic and non-enzymatic 
antioxidants, may be considered to be able to prevent the oxidative-related disorders. 
Traditional Chinese medicines (TCM) that are rich in antioxidants may play a key 
role in the prevention of the disease (Fig 1.4). 
I C h i n e s e herbal Medicines 
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Fig 1.4 Interrelation between ROS and antioxidants. (Zhu et al., 2004) 
1.7 Traditional Chinese Medicine (TCM) 
While the current western medications are criticized for their expense and 
undesirable adverse effects, especially for their long term administration, TCM is 
famous for its lower cost and less side effect. As CVD can start as early as 
adolescence asymptomatically, primary prevention of the disease is important. It is 
worth looking for an effective TCM at the point of view of prevention. 
TCM is a modem compilation of traditional Chinese medicine which includes the 
traditional medical practices originated in China. TCM has developed for over 
several thousand years since the Yellow Emperor who composed the “Huangdi 
Neijing”. The practices include theories, diagnosis and treatments such as herbal 
medicine, acupuncture and massage. 
The theory of TCM is based on a holistic view on diseases. Illness in TCM is 
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regarded as a lack of harmony. It emphasizes that a balanced human body can resist 
bacteria and virus or other causes that lead to a disease. Therefore, the goal of the 
treatment is to assist the body to regain balance and improve homeostasis. There is a 
saying "Chinese medicine treats humans while western medicine treats diseases". 
Western medicine treats diseases by targeting the origin directly while TCM 
recognizes the importance of maintaining health to prevent from getting ill. 
TCM has been very effective in the treatment of diseases such as cardiovascular, 
immunogenic, tumors, bone fracture, the cravings and withdrawal symptoms of drug 
addicts and to assist recovery from the surgery. TCM practices are believed to be able 
to offer palliative effect on some diseases which the western medicine fails to cure 
and to off set the side effect caused by the western medical treatment, e.g. 
chemotherapy in treatment of cancer. Also, traditional Chinese diagnostics and 
treatments are often much cheaper than western methods. Many Chinese herbal 
medicines are marketed as dietary supplements. Yet, there is still considerable 
controversy over the effectiveness, safety, and regulatory status of these substances. 
Danshen and Gegen are two herbs which have long been used in the treatment of 
cardiovascular diseases in TCM. Many extensive studies have been carried out to 
reveal the effectiveness of these two herbs. The active constituents have been 
identified with the corresponding effects and efficacies proved. 
1.7.1 Danshen 
Danshen is the dried root of Salvia miltiorrhiza that belongs to the family of Labiatae 
(Lam et al, 2007). It is a traditional Chinese medicine commonly used for the 
treatment of cerebrovascular diseases and cardiovascular diseases. Fufang, i.e. 
compound formula, with other herbs is often used. 
Danshen is bitter in flavour and slightly cold in nature. It acts on the heart and liver 
channels. According to the therapeutic theory of Chinese medicine, Danshen is 
effective in activating circulation and dispersing stasis or sludging of blood (Cheng, 
2006). It can also clear heat from the blood, resolve swelling and tranquilizing the 
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mind (Chan et al., 2004). 
Danshen is able to inhibit angiotensin converting enzyme (ACE) (Kang et al., 2003), 
lower blood pressure, and dilate arteries (Lei and Chiou, 1986). The vasorelaxant 
action of Danshen was shown to be endothelium independent (Leung, 2003). A 
possible mechanism was by the inhibition of Ca^^ influx in the vascular smooth 
muscle cells and a small component was mediated by the opening of K+ channels 
(Lam et al., 2007). Danshen was shown to protect the myocardium from reperfusion 
injury of the ischaemic heart (Leung, 2003), and enhance the tolerance of ischaemic 
tissue to hypoxia (Li and Liu, 2000). The mechanism may involve the ability of 
Danshen to enhance antioxidant defense enzyme activities to decrease or abolish the 
production of free radicals (Ji et al., 2003). It also improved microcirculation in 
coronary patients (Jin, 1978) and was used to treat patients with angina pectoris 
(Cheng, 2006), myocarditis and myocardial infarction (Zhao et al., 1996). 
Danshen can reduce thrombosis by its anticoagulant effect. It has been found to 
increase the proteolysis of fibrinogen to fibrinogen degradation products (Wang et al., 
1978). Other effects of Danshen include anti-inflammation (Kang et al,, 2000), free 
radical scavenging, mitochondrial protection effects (Zhou et al., 2003) and lipid 
lowering effect. In an in vitro system, Danshen extract also promoted cell growth and 
differentiation of SVR endothelial cells. It enhanced the angiogenic process through 
up-regulation of VEGF and its receptor genes (Lay et al, 2003). Danshen extract 
also protected human umbilical vein endothelial cells (HUVEC) against the 
ho mo cysteine-induced adverse effect in vitro (Chan et al, 2004). 
Many active constituents were found in the lipid-soluble and water-soluble fractions. 
The lipid soluble fraction contains tanshinone I, tanshinone IIA, IIB and other 
tanshinone derivatives. The water-soluble constituents consist of danshensu, 
salvianolic acid B (SAB), lithospermic acids, protocatechualdehyde, and rosemarinic 
acid (Chan et al., 2004). Danshensu and SAB were found to inhibit platelet 
aggregation (Li et al” 1983) and inhibited tumor necrosis factor (TNF-a) induced 
endothelial permeability (Ding et al., 2005) which are implicated in inflammation 
and the subsequent development of atherosclerosis. In addition, danshensu could 
scavenge superoxide radicals generated fi-om the xanthine and xanthine oxidase 
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system (Zhao et al., 1996). SAB was found to be an antioxidant that scavenged 2,2-
diphenyl-/-picrylhydrazyl (DPPH) radicals, inhibited Cu^^-induced LDL oxidation 
and raised the vitamin E content in LDLs (Wu et al, 1998). Also, it down-regulated 
the cell adhesion molecules expression, VCAM-1 and ICAM-1, on the human aortic 
endothelial cells (HAECs) (Chen et al., 2001). Magnesium lithospermate B showed 
neuroprotective effect against ischemic stroke (Tzen et al., 2007). Tanshinone could 
scavenge lipid free radicals generated from lipid peroxidation (Zhao et al., 1996). 
Sodium tanshinone IIA sulfonate, a tanshinone IIA derivative, was found to reduce 
myocardial infarct size, prolong the survival of cultured human saphenous vein 
endothelial cells (Wu et al., 1993). 
1.7.2 Gegen 
Gegen refers to the dried root of two Pueraria genus under the Leguminosae family, 
Pueraria lobata (Willci.) Ohwi (Yege in Chinese) and Pueraria thomsonii Benth 
(Fenge in Chinese). It is pungent and sweet in flavour and cool in nature. It acts on 
the spleen and stomach channels. It can relieve fever and dysentery, promote the 
production of body fluid, facilitate eruption, and lessen stiffness and pain of the nape 
(Jiangsu New Medical College, 1986). It is also applied as a diaphoretic, 
antidipsotropic and antiemetic agent (Keung et al., 1996; Xie et al., 1994). 
Furthermore, it is active against angina pectoris, hypertension, deafness, optic nerve 
atrophy or retinitis (Huang, 1993). 
The common aqueous constituents of the two herbs are daidzein, daidzin, puerarin 
and 5-hydroxypuerarin. Besides, Yege contains also 3'-hydroxypuerarin and 3'-
methoxypuerarin. The HPLC chromatograms also showed a higher content of 
daidzein, daidzin and puerarin in Yege than in Fenge. Besides, in the 2,2-azobis(2-
amidinopropane) dihydrochloride (AAPH)-induced red blood cell (RBC) hemolysis, 
Yege aqueous extract inhibited RBC damage while Fenge showed no effect at all 
(Jiang et al., 2005). 
The advantage of Yege over Fenge is its more potent antioxidant activity and 
vasorelaxant effect. The higher content of the isoflavonoids in Yege than those in 
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Fenge may account for this. The antioxidant activity of Yege supported the clinical 
usage of this herb in the prevention and treatment of cardiovascular disease. 
Puerarin, the most abundant isoflavone glucoside of Gegen, was found to inhibit 
vascular endothelial cell apoptosis in a chemical hypoxia-ischemia in vitro model. 
The effect was partly due to the decrease of caspase-3 expression (Shi and Zhang, 
2003). It was also found to act as a p-adrenoreceptor antagonist in isolated arteries 
and veins (Wang et al” 1994). Daidzin was reported to account for the 
antidipsotropic activity (Lin et al” 1996). 
In this project, the Gegen used was Pueraria lobata (Yege). 
1.7.3 Danshen-Gegen Compound Formula (DG) 
In TCM, Danshen and Gegen were widely employed for the treatment of cerebral-
vascular diseases and cardiovascular diseases. Studies from our laboratory have 
demonstrated some of the anti-atherosclerotic effect of the Danshen-Gegen 
compound formula. 
From "Zhong yao fang ji xian dai yan jiu da dian"《中藥方劑現代硏究大典》 
(1996), Danshen and Gegen were included in 34 compound formula in which 28 
were aimed for cardiovascular tonic. The simplest formula consists of only Danshen, 
Gegen and Yuanhu (元胡）in the ratio 6:3:1. The main contribution ofYuanhu was its 
analgesic effect. Yet, it may mask angina pectoris, if any, which is the main cardiac 
symptom. After omitting Yuanhu, further experiment on the antioxidative effect, 
vasodilation study, protection of myocardium in ischemic heart and anti-platelet 
study were taken. It was found that Danshen/Gegen in 7:3 is the most effective ratio. 
Moreover, the compound formula showed synergistic vasodilative effect and some of 
the underlying mechanisms were identified (Leung, 2003; Yam, 2005). 
In addition, the Danshen/Gegen extract showed inhibitory effect on PDGH-induced 
proliferation and migration of vascular smooth muscle cells in vitro and the 
hypocholesterolemic effect on diet-induced hyperlipidemia in rabbit model (Koon, 
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2006). 
A 24-week clinical trial of this compound formula on the secondary prevention of 
coronary heart disease was carried out. The patients were found to attain an improved 
lipid profile, vascular function and structure after the treatment (Tarn, 2004). 
Due to the positive anti-atherosclerotic results of the compound formula, it was 
further investigated for its preventive effect on CVD. 
1.8 Aim of Study 
Cardiovascular disease is the leading cause of mortality and morbidity in the world 
especially in developed countries. The prime cause is atherosclerosis. Reactive 
oxygen species (ROS) have emerged as critical molecules in the pathogenesis of the 
chronic and fatal disease. 
Atherosclerosis and CVD develops slowly and can start as early as adolescence 
asymptomatically, we may only get notice when symptoms like chest discomfort 
appear. Apart from focusing on relieving the symptoms resulting from atherosclerosis, 
the more effective implication should be the primary preventive measures on 
decreasing the underlying cause of atherosclerosis. In this case, ROS contribute to 
the initiating stage and progression of CVD, such as endothelial dysftmction, LDL 
oxidation and thus foam cell formation. To start prevention at a time before fatty 
streaks begin forming, foam cell formation inhibition and antioxidant system 
improvement may be the key. 
Although various western medical treatments have been developed, none of which is 
capable in curing the disease completely. Moreover, different undesirable adverse 
effects have been identified especially in their long-term administration. On the other 
hand, TCM is famous for its lower cost and smaller side effect. It is worth looking 
for an effective TCM at the point of view of prevention. Danshen and Gegen are two 
herbs which have long been used in the treatment of cardiovascular diseases in TCM. 
As the Danshen-Gegen (7:3) compound formula showed positive anti-atherosclerotic 
results, it is further investigated for its preventive effect on CVD. 
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The intake in diet of antioxidant compounds or compounds that can reinforce the 
antioxidant power can be considered to be able to prevent the oxidative-related 
disorders. While the previous studies mainly focused on the vasodilative effect, lipid 
lowering effect and the treatment efficacy, the objective of this study is to determine 
the effect of the Danshen-Gegen compound formula on 1) in vitro foam cell 
formation and 2) in vivo antioxidant level, to reveal the potential of the compound 
formula to be developed as a dietary supplement for normal rats to reinforce the 
antioxidant power, so as to prevent the development of CVD. Also, advanced age is a 
high risk factor of CVD probably due to the declined antioxidant level. Different age 
groups, who possess different antioxidant levels, may give different response toward 
antioxidant treatment. Therefore, another aim is to 3) investigate and compare the 
effect of the compound formula on aged rats. 
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Chapter 2 IN VITRO FOAM CELLS FORMATION 
2.1 Materials and Methods 
2.2 Result and Discussion 
2.3 Summary 
Foam cells formation is involved in the early stage of the development of the 
atheromatous plaque. It is due to over uptake of oxLDL by macrophages which then 
results in accumulation of cholesteryl esters inside the macrophages. Foam cells 
formation can be produced in vitro by incubating macrophages with acLDL. This 
simple model mimics the pathophysiological situation for the initial development of 
atherosclerosis and thus allows the determination of the efficiency of 
atheroprotective drugs. 
The effect of the compound formula on foam cells formation was investigated by co-
treating the resident peritoneal macrophages from Sprague-Dawley rats with the 
sample extract and acLDL. The cells were then stained with Oil red-O and observed 
under light microscope. 
2.1 Materials and Methods 
2.1.1 Materials 
Danshen {Radix Salviae Miltiorrhizae), which was grown in Sichuan, was purchased 
from a local herbal store in Hong Kong (永安fi"). Gegen {Puemria lobata (Willd.)), 
which was grown in Anhui, was purchased from a supplier in Guangzhou (通濟堂藥 
店）.Both of the herbal medicines were authenticated by Dr. Cao Hui (National 
Engineering Research Center for Modernization of TCM, Zhuhai, Guangdong, 
China). Morphological identification, thin layer chromatography (TLC) and 
microscopic structure identification were utilized for the qualitative assurance of the 
herbs. 
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Fig 2.1 Danshen {Salvia miltiorrhiza) 
國 
Fig 2.2 Gegen {Radix puerariae) 
Herbal Medicine Voucher Number 
Danshen 2005-2793 
Gegen 2005-2792c 
Table 2.1 Voucher numbers of the herbal medicines used. 
2.1.2 Methods 
2.1.2.1 Herbal Preparation by Hot Water Extraction 
The raw components of the two herbs were mixed with the ratio of Danshen:Gegen 
being 7:3. Twenty one kilograms of raw herb of Danshen and 9 kg of raw herb of 
Gegen were soaked with water in an extraction tank for about 1 hour. The extraction 
tank was heated under reflux with 210 L of water for 5 hours using extraction-
concentration system. The combined aqueous extract was then subjected to 
concentration for 1 hour 30 min under reduced pressure using the concentration 
system to give about 40 L of concentrated extract. A total of 40 L of concentrated 
extract was obtained from 30 kg of combined formulated raw herbs. The density of 
the concentrated extract was adjusted to 1.08-1.09 g/ml before spray-drying to give 
the powder extract. The compound formula sample extract was also used in the in 
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vivo study described in chapter 3. 
2.1.2.2 Resident Peritoneal Macrophages Preparation 
Three millilitre of 3% sterile thioglycolate was injected into the peritoneal cavity of a 
100 g male Sprague-Dawley rat. The rat was rested for 4 days. After cervical 
dislocation of the rat, its peritoneal cavity was washed with 25 ml of plain sterile 
RPMI medium 1640 (Gibco Cat #23400-021) containing 100 lU/ml penicillin and 
100 )ig/ml streptomycin (Gibco, Cat #15140-122). After centrifugation at 500xg for 
1 Omin, the cell pellet was collected and washed by phosphate buffer saline 
(PBS):dH20 (1:1) for 3 times to remove any red blood cells. The cells were diluted 
in complete RPMI medium. 
2.1.2.3 Colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl Tetrazolium 
Bromide (MTT) Assay 
MTT assay was carried out to determine the treatment time for foam cells formation. 
Reduction of MTT by mitochondrial succinate dehydrogenase gives a purplish-blue 
formazan product, of which amount is measured and reflects the cell viability 
indirectly (Mosmann, 1983). The cell suspension (7x10'^  cells/well) in completed 
RPMI medium containing 10% FBS (Gibco, Cat #12657-029) was seeded in a 96-
well plate. The plate was incubated at 37°C in a 5% carbon dioxide for 2 hours. Non-
adherent cells were washed away by PBS and the remaining monolayer was 
macrophages. 
The cells were treated with 0.1, 0.2, 0.4, 0.8 and 1.6 mg/ml of sample extract for 48, 
52 and 72 hours. All culture medium was discarded and 50 \x\ of MTT solution (1 
mg/ml) was added in each well and the cells were incubated for 4.5 hours in dark at 
37°C in a 5% CO2 air atmosphere. After that, MTT solution was removed and 100 
of dimethylsulphoxide (DMSO) (Sigma, Cat #05879) was added in each well. The 
plate was allowed to shake for 20 min. The absorbance of the cells at 540 nm was 
measured by a microplate reader (FLUOStar). The experiments were carried out in 
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eight replicates. The number of viable cells was proportional to the measured 
absorbance at 540 nm. 
2.1.2.4 DG Effect on in vitro Foam Cells Formation 
The cell suspension was seeded in a 24-well plate at 3x10^ cells/well. The plate was 
incubated for 2 hours at 37°C in a 5% CO2 air atmosphere. Non-adherent cells were 
washed away by PBS and the remaining monolayer was macrophages. 
The cells were co-treated with 0.2, 0.4, 0.8 and 1.6 mg/ml of sample extract and 100 
|j.g/ml of acetylated low-density lipoprotein from human plasma (acLDL) (Invitrogen, 
Cat #L35354) for 48 hours. 
Oil Red-O Staining 
The cell monolayer was fixed with 2% of para-formaldehyde for 30 mins at room 
temperature. The cells were then washed once with PBS. Saturated Oil red-O 
(Sigma-Aldrich, Cat #00625) in isopropanol (Lab-Scan, Cat #G4515) was diluted 
with distilled water at 3:2 v/v ratio and allowed to stand for 10 min. The diluted Oil 
red-O was filtered and immediately used to stain the washed cells for 15 min. Oil 
red-O is specific for neutral lipids. The cells were washed twice by PBS. The cells 
were observed under light microscope (Olympus 1X71). 
2.2 Results and Discussion 
Hot water extraction of herbal medicines, as a tea or a decoction, for chronic 
conditions is common in TCM. In the extraction process of the herbs, the total 
weight of dry powder obtained was 5495 g. The extraction efficiency was 18.3% 
(5.495 kg/30 kg X 100%). 
From the MTT assay (Fig 2.3)，the optimal treatment time was determined to be 48 
hours as the viability of the peritoneal macrophages appeared to decrease beyond 48 
hours while shorter time interval was not long enough for significant foam cells 
formation (data not shown). 
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MTT Assay -Rat Pe11toneal Macrophage Viability over Time 
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Fig 2.3 The viability of the rat peritoneal macrophages measured by MTT assay 
expressed as the absorbance at 540 nm against different time intervals and dosages of 
DO extract. Results are expressed as the mean ± SD (n = 5). 
In the absence of acLDL, the macrophages typically contain little to no cholesteryl 
ester. Incubation of the macrophages with acLDL led to additional accumulation of 
cholesteryl esters. As Oil red-O is specific for neutral lipids, normal macro phages 
which do not contain high level of cholesteryl ester are not coloured while those 
incubated with acLDL becalne highly colourable with Oil red-O characterized by 
numerous red lipid droplets and whorls in the cytoplasm. Also, the bigger size was 
also a characteristic of foam cells. In contrast, when the macro phages were treated 
with acLDL and different dosages of DO (0.2, 0.4, 0.8, 1.6 Ingltnl), the number of 
lipid droplets decreased. For the doses above 0.8 mg/ml, coloured lipid droplets were 
not found in the cells indicating that foam cells formation was inhibited. These 
results showed that DO blocked the transformation of macrophages into foam cells. 
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Fig 2.4 Staining of neutral lipids with Oil red-0 of rat peritoneal macrophages 
(200x). A, normal rat peritoneal macrophages without addition of acLDL or DG B-F, 
rat peritoneal macrophages treated 48 hours with 100 |ig/ml acLDL plus solvent 
vehicle (panel B), or 100 |ig/ml acLDL plus 0.2 mg/ml DG (panel C), or 100 |ig/ml 
acLDL plus 0.4 mg/ml DG (panel D), or 100 |ig/ml acLDL plus 0.8 mg/ml DG 
(panel E), or 100 p.g/ml acLDL plus 1.6 mg/ml DG (panel F). Data are representative 
of three repeated experiments. 
In the present study, the atheroprotective effect of DG on foam cells formation was 
tested in vitro. Foam cells formation is involved in the early stage in the pathogenesis 
of atherosclerosis. The cytological study showed that DG inhibited the accumulation 
of neutral lipids in macrophages stimulated by acLDLs and prevented their 
transformation into foam cells. This supports that DG can block the step that proceed 
to the atheromatous plaque formation. 
The present observation was comparable to an in vitro study on the effect of an 
herbal preparation containing both Danshen and Gegen (Fenge) on foam cells 
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formation (Sieveking et ai, 2005). The herbal preparation was tested at 
concentrations ranging from 0.1-1.0 mg/ml, which were thought to be relevant for 
pharmacological effects in humans. Human monocyte derived macrophages 
(HMDMs) were incubated with acLDL and treated with the herbal preparation. The 
free cholesterol and cho lest eryl esters (CE) were isolated from the cell extracts and 
quantified by HPLC. The herbal preparation led to a dose-related decrease in the 
amount of free cholesterol and total cho lest eryl esters accumulation in the HMDMs 
(Fig 2.5). 
Cholesterol + C.E. in Lipid-loaded HMDM 
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Fig 2.5 Total cholesterol and cho lest eryl ester content of human macrophages loaded 
with acLDL. Results are expressed as the mean 士 SEM. *尸<0.05, **；7<0.01, 
***/7<0.001 by ANOVA. (Sieveking et al., 2005) 
Provided that DG can lower the CE accumulation level, the present study showed the 
extent of suppression on the CE content that is necessary to inhibit the morphological 
change of macrophages into foam cells. Besides, the herbal preparation by Sieveking 
et al. differs from the present herbal extract in that Yege was used instead of Fenge. 
Although Yege and Fenge are under the same family consisting of similar active 
components, Jiang et ^//.(2005) has shown a higher content of the isoflavonoids in 
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Yege than in Fenge. Thus, Yege outdoes Fenge by its higher potency of antioxidant 
activity. Thus, DG showed similar inhibitory effect on foam cells formation. 
The mechanism for DG to reduce lipid loading in macrophages is still unclear. 
However, many studies have pointed out that both Danshen and Gegen possess 
antioxidant components such as the flavonoids and isoflavones. These antioxidants 
inhibit LDL oxidation. LDLs are rich in polyunsaturated fatty acids, and they possess 
endogenous antioxidant defense. Oxidation of LDL involves the process in which 
polyunsaturated fatty acids are oxidized and automatically degraded to produce a 
variety of aldehydes and related products (Sanchez-Moreno et al., 2000). SAB from 
Danshen was found to scavenge DPPH radicals, inhibited Cu^^-induced LDL 
oxidation and raised the vitamin E content in LDLs (Wu et al., 1998). In the AAPH-
induced red blood cell (RBC) hemolysis, Yege aqueous extract inhibited RBC 
damage (Jiang et al,, 2005). In addition, some flavonoids can inhibit modification of 
LDL by macrophages and thus also reduce oxLDL (Miura et al., 1995). These 
suggest that the antioxidative effect of DG can attenuate the ROS level and thus the 
oxidative stress on LDLs by scavenging free radicals, and also improve the resistance 
of LDLs against the oxidative modification. These lower the accumulation of 
cholesteryl esters in macrophages and hence foam cells formation. 
Nevertheless, the present in vitro study determined the effect of DG on foam cells 
formation using acLDL, a modified form of LDL. This suggests that DG inhibited 
macrophage lipid loading by an alternative mechanism apart from its antioxidative 
capacity. The regulation of lipid loading relies on the balance between lipoprotein 
uptake and cholesterol efflux. Either the decrease in uptake or increase in efflux, or 
both, would inhibit the formation of foam cells, and vice versa. It was suggested the 
observed effect of DG may be due to its high flavonoid content of the extract and its 
ability to regulate the cholesterol metabolism by up-regulating free cholesterol efflux 
in macrophages, and down-regulating the enzymes ACAT-1 and ACAT-2 (Sieveking 
et al., 2005). 
The ATP-binding cassette protein (ABC) Al plays a key role in cholesterol efflux. It 
is a trans-membrane protein that regulates the transfer of cholesterol and 
phospholipids to apolipoprotein Al, an initial step of high-density lipoprotein (HDL) 
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formation and reverse of cholesterol transport (Tall et al., 2002). This protein can be 
transcriptionally inhibited by angiotensin II，a potent vasoconstrictor. Angiotensin 
converting enzyme (ACE) catalyses the conversion of angiotensin I to angiotensin II. 
It was demonstrated that chronic angiotensin II infusion substantially promotes foam 
cells formation in low-density lipoprotein receptor-deficient mice and significantly 
reduces ABCAl mRNA expression in peripheral macrophages (Takata et al., 2005). 
On the other hand, ACE plasma activities were significantly inhibited by the addition 
of Danshen extract, with lithospermic acid B being the active principle, in a dose-
dependent manner (Kang et al., 2003). Inhibition of ACE would result in decreased 
formation of angiotensin II. Thus, Danshen may be able to inhibit ACE activity, 
reduce angiotensin II and hence up-regulate ABCAl and cholesterol efflux, thus to 
maintain cholesterol homeostasis in macrophages. 
ACAT is an important enzyme catalyzing the formation of cholesteryl esters thus 
leading to CE accumulation in macrophages. Beside macrophages, ACAT is present 
in a variety of tissues including the liver. ACAT inhibitors were shown to block the 
formation of foam cells, and prevent the appearance of atheromatous lesions and 
lipid deposition (Matsuda, 1994). Several studies on ACAT activity regulation have 
been reported. Tamoxifen is a selective estrogen receptor modulator used for the 
treatment and prevention of breast cancer. It is a weak estrogen that is used in the 
hormonal therapy for menopausal women. It was shown that tamoxifen inhibited 
ACAT in a concentration-dependent manner on rat liver microsomal extract (Medina 
et al., 2004). In addition, tamoxifen also inhibited ACAT in intact macrophages 
stimulated by acLDL and thus blocked the formation of foam cells. Besides, it has 
been reported to stimulate the production of transforming growth factor-|3 (Grainger 
et al., 1995), which was shown to enhance ABC transporters in foam cells (Argmann 
et al” 2001). Thus, free cholesterol efflux could be up-regulated. On the other hand, 
Gegen is rich in flavones which also possess certain kinds of estrogen-like effect. 
These phytoestrogens have a similar chemical structure to estrogen, and could bind 
to the estrogen receptor-p. It was shown that extract of Gegen had an estrogen-like 
regulating effect on lipid metabolism in liver (Wang et al., 2004). Hence, being 
estrogen receptor ligands, extract of Gegen may possess similar effect to that of 
tamoxifen in ACAT inhibition and cholesterol efflux up-regulation. 
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Other studies also demonstrated that flavonoids are capable to modulate the activity 
of P-glycoprotein, a membrane transporter protein. Inhibition of such protein would 
result in decreased cholesterol esterification (Conseil et al., 1998). 
2.3 Summary 
Foam cells formation can develop into atheromatous plaque and is involved in the 
early pathology of atherosclerosis. By the present study, DG inhibits foam cells 
formation totally at the dose above 0.8 mg/ml. This correlates to an in vitro study on 
the Danshen-Fenge effect on the total cholesterol and cholesteryl ester accumulation 
in human macrophages loaded with acLDL. However, the underlying mechanisms 
are still unclear. Possible reasons include DG's antioxidative properties that can 
inhibit LDL oxidation and thus reduce uptake by macrophages. Also, the ability of 
DG to modulate the enzymes involved in the uptake or the molecules involved in the 
cholesterol efflux may contribute, at least partly, to the observed anti-atherosclerotic 
effect of DG 
39 
Chapter 3 In vivo Antioxidant Level 
Chapter 3 IN VIVO ANTIOXIDANT LEVEL 
3.1 DG Effect on in vivo Antioxidant Levels on Young-adult Wistar Rats 
3.1.1 Materials and Methods 
3.1.2 Results and Discussion 
3.2 DG Effect on in vivo Antioxidant Levels on Middle-aged Wistar Rats 
3.2.1 Materials and Methods 
3.2.2 Results and Discussion 
3.3 Summary 
Currently, antioxidants are a popular topic for their preventive and treatment roles in 
cardiovascular disease. Healthy cells can scavenge free radicals effectively by their 
antioxidant system and maintain a dynamic relationship between ROS and 
antioxidants in the body. In some pathological conditions, e.g. cells suffering 
ischaemic insult, the sudden generation of ROS can upset this balance. Natural 
antioxidants including SOD, CAT and GPx may then be depleted resulting in 
accumulation of ROS (Zhu et al.’ 2004), The intake in diet of antioxidant compounds 
that can reinforce the antioxidant system may be considered to be able to prevent the 
oxidative-related disorders. In such situation, exogenous antioxidants intake for ROS 
neutralization or enhancement of activities of original natural antioxidants can play 
an important protective role for the development of CVD. 
In the present study, two groups of normal male Wistar rats of different ages, young-
adult (3-month-old) and middle-aged (10-mo nth-old) were studied. 
3.1 DG Effect on in vivo Antioxidant Levels on Young-adult Wistar Rats 
3.1.1 Materials and Methods 
Materials 
3.1.1.1 Herbal Preparation by Hot Water Extraction 
DG extract described in the previous chapter (section 2.1.2.1) was used. It was 
dissolved completely in water to produce the required concentration. 
40 
Chapter 3 In vivo Antioxidant Level 
3.1.1.2 Assay Kits 
The SOD Assay Kit-WST was provided by Dojindo Molecular Technologies, Inc. 
(Cat #S311). GST Assay Kit was provided by Cayman (Cat #703302). Catalase 
Assay Kit was provided by Merck, Calbiochem (Cat #219265). GPx Assay Kit was 
provided by Merck, Calbiochem (Cat #353919). 
3.1.1.3 Antibodies for Protein Expression Determination in Organs 
Primary antibody: Rabbit anti-SOD antibody was purchased from Santa Cruz 
Technology, USA (Cat #sc-11407). Mouse anti-Catalase antibody was purchased 
from Sigma (Cat #C0979). Rabbit anti-GPx antibody was provided by ABCam (Cat 
#abl6798). Mouse anti-GAPDH was purchased from Ambion (Cat #AM4300). 
Mouse anti-P-actin was purchased from Sigma (Cat #A2228). 
Secondary antibody: Anti-rabbit antibody was purchased from Bio Rad (Cat #172-
1013). Anti-mouse antibody was purchased from Zymed (Cat #81-6520). 
Methods 
3.1.1.4 Animals and Experimental Design 
DG was applied intra-gastrically to the normal young-adult male Wistar rats (3-
month-old) for twelve weeks. The rats were divided into four groups: 1) negative 
control: water; 2) positive control: 6.2 mg/kg of vitamin C; 3) Ix: 0.3 g/kg of DG; 
and 4) 3x: 0.9 g/kg of DG. Rats were housed under constant conditions of 
temperature, humidity and standard light-dark cycle (12 hours/12 hours). They had 
free access to water and food. 
Each four weeks, plasma was collected to monitor the levels of some major 
antioxidants and ROS detoxification enzymes. About 1.5 ml blood was collected 
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from the tail tip of the rats using micro tube that contained 10 |jJ of 1250 U/ml PBS 
heparin (Sigma, Cat #H5027). The collected blood was put on ice immediately. 
Plasma was collected by centrifoging the blood at 10500xg for 5 min at 4°C. The 
plasma was used for the subsequent assays on antioxidants. 
After twelve weeks, all rats were terminated by decapitation and organs were isolated 
for determining the level of lipid peroxidation and the protein expression of the 
antioxidant enzymes. 
3.1.1.5 Plasma Antioxidants 
Plasma collected in each four weeks was tested with plasma total antioxidant level, 
activities of SOD, CAT, GPx and GST, and the content of a-tocopherol and ascorbic 
acid. 
3.1.1.5.1 Plasma Total Antioxidant Level 
The total antioxidant level was measured by ABTS + Radical Cation Decolorization 
Assay (Re et al., 1999). Trolox (Aldrich, Cat #238813) was used as the standard 
which was dissolved in PBS at pH 7.4 to give a 5 mM stock solution. 2,2-azino-
bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) (Sigma, Cat 
#A1888) and potassium persulfate (Sigma-Aldrich, Cat #379824) were prepared in 
distilled water to give a 7 mM and 140 mM stock solution, respectively. Then, 178 [i\ 
of potassium persulfate was mixed with 10 ml of ABTS stock to obtain a final 
concentration of 2.45 mM. As the reaction stoichiometrical ratio of ABTS:potassium 
persulfate equals 2:1, this would result in incomplete oxidation of the ABTS. 
Oxidation of the ABTS commenced immediately, but the absorbance only reached 
maximal and stable after 6 hours. Thus, the mixture was allowed to stand in dark at 
room temperature overnight before use for the production of ABTS radical cations 
(ABTS +).The radicals were stable for 2-3 days in dark at room temperature. Stock 
42 
Chapter 3 In vivo Antioxidant Level 
solutions of plasma were diluted for 6 folds such that a 10 |il aliquot would produce 
20% - 80% inhibition of the blank absorbance. 
The ABTS + solution was diluted with PBS such that O D 7 3 4 = 0.700 士 0.020. One 
hundred millilitre of PBS was mixed with about 1.5 ml ABTS +solution to obtain the 
optimal OD. Ten micro litre of the diluted plasma or Trolox standards (from 0 to 2 
mM) was added to 0.99 ml of diluted ABTS + solution. The absorbance reading at 
734 nm was taken at exactly 6 min after initial mixing. The determination was 
repeated in triplicate. The percentage inhibition of absorbance was calculated using 
the following equation: 
% inhibition = [(ODPBS 一 ODsampie) / ODPBS ] x 100% 
A standard curve was constructed by plotting the percentage inhibition against Trolox 
standards concentration. The total antioxidant level of plasma was expressed as 
concentration of Trolox equivalent. 
3.1.1.5.2 SOD, CAT, GPx Activities 
The plasma SOD activity was measured by the SOD Assay Kit - WST from Dojindo 
Molecular Technologies. A formazan dye was produced from the tetrazolium salt 
provided upon the reduction of a superoxide anion. At the same time, the production 
of superoxide anion was inhibited by SOD in plasma. Thus, after the incubation at 37 
min for 20 min, the SOD activity could be quantified as an inhibition activity by 
measuring the inhibition in the color development at 450 nm. The detailed protocol 
as described in the technical manual provided by Dojindo Molecular Technologies 
(Cat #S311) was followed. 
The plasma CAT and GPx activities were measured by assay kits purchased from 
Calbiochem. 
The Catalase Assay Kit measured the peroxidatic function of CAT in the presence of 
methanol. Formaldehyde was produced and gave rise to a purple color after the 
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addition of the chromogen. Hence, the CAT activity was determined by measuring 
the increase in the absorbance at 540 nm. The detailed protocol as described in the 
user protocol provided by Calbiochem (Cat #219265) was followed. 
The Glutathione Peroxidase Assay Kit measuring the GPx activity indirectly by a 
coupled reaction involving glutathione reductase (GR) was used. Oxidized 
glutathione (GSSG) produced was recycled to its reduced state by GR at the expense 
ofNADPH. Thus, the GPx activity was determined by measuring the rate of decrease 
in absorbance at 340 nm due to the oxidation of NADPH to NADP+. The detailed 
protocol as described in the user protocol provided by Calbiochem (Cat #353919) 
was followed. 
3.1.1.5.3 HPLC Analysis of Vitamin E (a-tocopherol) 
The plasma a-tocopherol (vitamin E) content was also estimated by HPLC (System 
Gold, Beckman Coulter). 
Four hundred micro litre of plasma was added to 400 |j,l water to dilute the solution to 
facilitate the separation of phases. Fifty microgram of internal standard 6-tocopherol 
(10 III of 5 mg/ml) (Supelco, Cat #47784) was added. Two millilitre of ice-cold 
absolute ethanol was added to precipitate the proteins. Two millilitre of n-hexane 
(Lab-Scan, Cat #P5536) containing 0.025% butylated hydroxytoluene (BHT) (Sigma, 
Cat #B1378) was added. The mixture was vortex for 1 min. After agitation, the 
mixture was centrifliged at 3800xg for 5 min and the supernatant phase was collected. 
The organic supernatant phase contains the tocopherols (a-T usually represents 90% 
or more). Two millilitre of n-hexane containing 0.025% BHT was added again to 
repeat the extraction process to facilitate the extraction of tocopherols. The upper 
hexane layer was evaporated under stream of N2 gas (Bourgeois, 1992). The extract 
was re-dissolved in 260 |LI1 methanol (Tedia, Cat #MS 1922-001) and subjected to 
HPLC analysis. Twenty micro litre was injected for each run. 
The eluent used was 98% methanol and 2% water. The HPLC column was stabilized 
for at least 2.5 hours before injection of samples. a-Tocopherol standards (0.00625, 
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0.0125, 0.025, 0.05 and 0.1 mg/ml) (Sigma, Cat#T3251) were dissolved in methanol. 
20 |al was injected into the C-18 reverse phase column (4.6 mm x 250 mm, Beckman 
Ultrasphere Octadecylsilyl (ODS) column, Cat# 235329). The flow rate was 1 
ml/min. The UV detector at 220 nm of Detection system (System Gold, Beckman 
Coulter) was used. With the flow rate at 1 ml/min, the retention time of 5-tocopherol 
was about 10.7 min and that of a-tocopherol was about 15 min. 
3.1.1.5.4 HPLC Analysis of Vitamin C (L-Ascorbic Acid) 
The plasma L-ascorbic acid (vitamin C) was estimated by high pressure liquid 
chromatography (HPLC) (System Gold, Beckman Coulter) as described (Karlsen et 
fl/.,2005). 
Two hundred micro litre of plasma was mixed with 0.2 ml of ice-cold 10% (w/v) 
metaphosphoric acid (MPA) (Sigma, Cat #M6288) containing 0.54 mM Na2EDTA 
(Amresco, Cat #0105). It was vortex-mixed for 30 seconds and the samples were 
stored at -80°C until analysis. MPA was used for stabilization of vitamin C and 
precipitation of sample proteins. Due to rapid degradation of AA, procedures 
between sampling and preservation could not be delayed. 
After thawing, the samples were centriftiged at 3500xg for 10 min at 4°C to remove 
the precipitated plasma proteins. The supernatant was subjected to HPLC analysis. 
The eluent used was sodium acetate (40 mM) (Sigma, Cat #S8750), NazEDTA (0.54 
mM), dodecyltriethylammonium phosphate (1.5 mM) (Regis Tech Inc., USA, Cat 
#404021) and 7.5% methanol, taken to pH 4.75 by acetic acid (Scharlau, Cat 
#AC0352). Due to the polar nature and small molecular weight, regular reversed 
phase has little retention on AA. Thus, dodecyltriethylammonium phosphate was 
used as an ion-pair reagent in the mobile phase to obtain higher retention. NaiEDTA 
was added in the mobile phase to chelate trace metals in the samples (Karlsen et al, 
2005). 
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The HPLC column was stabilized for at least 3.5 hours before injection of samples. 
L-ascorbic acid standards (0.003125, 0.00625, 0.0125, 0.025 and 0.05 mM) (Sigma-
Aldrich, Cat #255564) were dissolved in PBS and then added to equal volume of 
10% MPA. They were filtered by the 0.22 |am Millipore filter and were then passed 
through a C-18 reverse phase column (4.6 mm x 250 mm, Beckman Ultrasphere 
Octadecylsilyl (ODS) column, Cat #235329). Twenty micro litre of standards or 
plasma samples was injected for each run. All the samples were kept on ice until 
before injection to avoid degradation of the plasma AA. It was shown that heparin 
plasma samples showed little AA degradation at +4°C for up to 4 hours but rapid 
degradation at short time intervals at room temperature (Karlsen et al , 2005). The 
ultraviolet detector at 264 nm of Detection system (System Gold, Beckman Coulter) 
was used. With the flow rate at 1 ml/min, the retention time of AA was about 7 min. 
3.1.1.6 Lipid Peroxidation and Protein Expression in Organs 
After 12-week treatment, all rats were killed by decapitation. The liver, brain and 
heart were collected. Defined portions of the organs were homogenized for lipid 
peroxidation determination by TBARS assay and protein expression determination 
by Western blotting. 
3.1.1.6.1 Organs Homogenization 
The liver, brain and heart were collected. After removing the fat tissue, if any, and 
rinsing with ice cold 0.9% (w/v) NaCl (Sigma, Cat #S9625), the organs were divided. 
The liver portion denoted by ‘‘#，，(Fig 3.1) was weighed and then homogenized for 
TBARS assay. The tissue was homogenized by Polytron (Kinematica, Cat 
#CMM105) in ice-cold homogenizing buffer (50 mM Tris, 0.1 mM EDTA, pH 7.6) 
in the ratio 1:10 (w/v). 
The defined portion (denoted by “*，，）of each organ (Fig 3.1-3) was chopped into 
small pieces and quick-frozen by liquid nitrogen. Then, the samples were stored at 
-80°C. They were later homogenized for protein expression determination by 
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Western blotting. 
I 
mmt,. _/通 Fig 3.1 The liver isolated for protein expression and lipid peroxidation determination. 
denoted for the section homogenized for Western blotting and “#，’ for the section 
for TEARS assay. 
Fig 3.2 The heart isolated for protein expression determination. “*，，denoted for the 
section homogenized. 
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Fig 3.3 The brain isolated for protein expression determination. denoted for the 
section homogenized. 
The “•，’ denoted section of each sample was homogenized in PBS containing 0.002% 
aprotinin (Sigma, Cat #A6279) using tissue grinder (Kontes, Cat #885450-0021). 
The homogenate was centrifuged at 1 OOOxg for 3 min and further washed twice by 
PBS containing 0.002% aprotinin. 
The cell pellet was then lysed by ice-cold lysis buffer (2% SDS (USB, #US75819), 
10% glycerol (USB, #US 16374), 0.0625 M Tris-HCl (USB, #US75825)) containing 
0.002% protease inhibitor aprotinin for 30 min at 4°C with occasional vortexing. The 
volume of lysis buffer added was calculated by the following ratio: 
weight of liver (g):vol (ml) = 1:2; 
weight of brain and heart (g):vol (ml) = 1:1 
The cell lysate was boiled at 99°C in the block heater (International Laboratory USA) 
for 10 min and then subjected to centriftigation at 10500xg for 20 min. The 
supernatant was transferred to a new microtube and was kept at -20°C before 
determination of protein concentration. 
3.1.1.6.2 TBARS Assay 
Thiobarbituric Acid Reactive Substances (TBARS) assay measures the tissue MDA 
level. Its concentration was expressed in terms of the standard 1,1,3,3-
tetramethoxypropane (TMOP) (Aldrich, Cat #108383). One millimolar TMOP was 
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prepared in 1% H 2 S O 4 . After standing for 2 hours in dark, the stock solution was 
diluted with 1% H 2 S O 4 to give 10, 20, 50, 100, 200 |iM standard series. TBARS 
assay was performed for the standard and the liver homogenate. Five hundred 
micro litre of sample was added with 500 |xl of 2-thiobarbituric acid (TBA) reagent 
(Sigma, Cat #T-5500) (0.67%) in 1:1 acetic acid to distilled water. Then, 225 i^l 
distilled water, 25 |il BHT (90 mM in isopropanol) and 250 |il FeCls (Merck, Cat 
#K26515845) (4 mM in distilled water) was added. After that, the mixture was 
incubated at 90°C for 30 min. Upon cooling, 2 ml butanol (Lab-Scan, Cat #A3527) 
was added and mixed. The mixture was centrifuged at 1800xg for 30 min. The upper 
layer, i.e. the butanol layer, was subjected to absorbance measurement at 532 nm. 
3.1.1.6.3 Protein Concentration Determination 
The protein content in the organ homogenate was quantified by the BCA protein 
assay kit (Sigma, Cat #B9643) using BSA protein standard through the measurement 
of absorbance at 562 nm by a microplate reader (SpectraMAX 250, Gene Co. Ltd.). 
A set of BSA standards at concentration of 12.5, 25, 50, 100, 200 and 400 |ig/ml was 
prepared. The sample was diluted by distilled water 50-fold. One hundred microlitre 
of working reagent from the BCA protein assay kit was added (50 parts of reagent A 
was vortex-mixed with 1 part of reagent B) into both sample and BSA protein 
standards. The microplate was incubated at 37°C for 30 min and the absorbance was 
then measured by the mircoplate reader (SpectraMAX 250, Gene Co. Ltd.) at 562 nm. 
The protein concentration was calculated in comparison with the BSA standard curve 
as follows. 
Actual protein concentration (|ig/|il) in sample 
=Protein concentration (|ig/ml) derived from the standard curve x 50* x 1000** 
*dilution factor 
** conversion factor 
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3.1.1.6.4 Western Blot Analysis 
Protein samples (30 - 100 jig) from the organ homogenate were analyzed by Western 
Blotting technique. The loading in each lane of samples consisted of 5 of 2x 
loading dye and a calculated volume of desired protein amount. Distilled water was 
added to make up the final loading volume to 10 \il The sample was heated for 5min 
at 99°C in a block heater before loading. 
The proteins in the cell lysate were loaded on a 4.5% stacking gel and 
electrophoresed on a 12.5% SDS separating gel. The glass plates were held by the 
casting frame. Three millilitre of 12.5% SDS separating gel was first added in 
between the two plates. The gel top was covered and flattened by isopropanol. After 
40 min for gel polymerization, isopropanol was poured off and the gel's top edge was 
washed by distilled water. The remaining water droplets were removed by filter paper. 
After that, 4.5% stacking gel was added on the top of the separating gel and the comb 
was inserted immediately. The gel was stood for 15 min. 
After the gel was polymerized, the comb was removed and the wells were washed 
twice with fresh Ix SDS running buffer (14.4 g glycine, 3.03 g Tris-base and 1 g 
SDS dissolved in 1 L of distilled water). The glass plates were put into the tank for 
Western blotting. The center of the tank was fully filled with fresh running buffer. 
Five micro litre of High range Rainbow Marker (Amersham Biosciences, Cat 
#RPN756) and 10 of samples were loaded into the wells using fine-tipped pipettes. 
The standard marker and the samples were migrated on the stacking gel at 65 V and 
were separated on the separating gel at 145 V until the end-point of the 
electrophoresis which was determined by the pre-stained protein standard marker. 
The separated proteins on the polyacrylamide gel were transferred to the Immuno-
BlotTM PVDF membrane, 0.45 |im for protein blotting (Millipore, Bio-rad 
Laboratories, Cat #162-0177), using the Semi-Dry Transfer Cell (Bio-Rad). The 
membranes were pre-wetted by methanol and then were shaken in freshly-prepared 
Ix e-blot buffer (14.4 g glycine and 3.03 g Tris-base dissolved in 500 ml of distilled 
water, followed by an addition of 100 ml of methanol). Filter papers were also pre-
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wetted with the e-blot buffer. The membrane sandwich was assembled with the 
following sequence from the positive side to the negative side: 2 filter papers, 
membrane, gel and 2 filter papers. Bubbles were squeezed out from the membrane 
sandwich by rolling a test tube on top. The transfer process was carried out at 
constant current (0.25 A for 2 membrane sandwiches) for one hour. The membranes 
were then shaken in the freshly-prepared blocking buffer (0.5% non-fat milk powder 
dissolved in TBST, 0.5% Tween-20 added to Ix TBS, 1.21 g NaCl and 8.77 g Tris-
base, pH 7.6) for one hour. 
The membrane was kept in a 50-ml centrifuge tube, probing with 3 ml of the 
corresponding diluted primary antibody in the blocking buffer according to the 
recommendation (Table 3.1). The centrifuge tube was rotated on a rotator kept at 4°C 
overnight. The membrane was then rinsed and washed by TBST on a shaker for 15 
min. It was then probed with 3 ml of the corresponding secondary antibody 
conjugated horseradish peroxide (HRP) for an hour at room temperature. The 
secondary antibody was diluted at 1:3000 by the blocking buffer. After rinsing the 
membrane, it was washed by TBST on a shaker for 45 min. It was kept in TBST until 
the detection process was performed. 
The protein of interest was visualized by the chemiluminent protein detection system. 
One milliliter of detection substrate buffer from the Supersignal® West Pico 
Chemiluminescent Substrate (Pierce, Cat #34080) was added on the membrane for 
1.5 min. In the dark room, the membrane was covered by an X-ray film in a film 
cassette with an optimal time and the film was developed by the X-ray film processor 
(Kodak). 
(3-actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were used as a 
loading control. After washing with TBST, the membrane containing brain and liver 
samples was re-probed with anti-P-actin primary antibody while the membrane for 
heart samples was re-probed with anti-GAPDH primary antibody. Detection was 
made according to the procedures described above. 
The films were scanned and quantified with the software ImageJ (NIH). The 
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integrated values for each band were taken and their ratios against P-actin or GAPDH 
were calculated. 
Integrated value of sample band Normalized band value for sample = Integrated value of p-actin or GAPDH band 
Relative quantity of the Normalized band value for sample 
= X 100% sample to control (%) Normalized band value for control sample 
Brand and Primary Approximate MW catalog Origin Dilution antibody of protein (kDa) number 
Santa Cruz Anti-SOD 16 rabbit 1:500 (#sc-11407) 
Sigma Anti-Catalase 60 mouse 1:1500 (# C0979) 
ABCam Anti-GPx 22 rabbit 1:2000 (#ab16798) 
Sigma Anti-P-actin 42 mouse 1:3000 (#A2228) 
Ambion Anti-GAPDH 36 mouse 1:3000 (#AM4300) 
Table 3.1 The antibodies used in protein expression determination. 
3.1.1.7 Statistics 
Data in all the assays are expressed as mean 士 S.E.M. The comparison between the 
means of treatment (vitamin C and DG) and negative control group of the same week 
was performed using two-tailed Mann-Whitney test.尸-values smaller than 0.05 were 
considered to be statistically significant. 
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3.1.2 Results and Discussion 
In this in vivo study, the animals were divided into 4 groups. The effect of treatment 
was compared to that of the negative control group, in which the rats were fed with 
water. 
The dosage of Ix group (0.3 g/kg) was corresponding to the human equivalent dose 
of a clinical study (Tarn, 2004). And the high dose group (3x) (0.9 g/kg) was 
included relative to the Ix group. Vitamin C treatment served as a positive control. 
Vitamin C (ascorbic acid) is a well studied micronutrient required for normal 
functioning of the body. Many biochemical, clinical and epidemiological studies 
have indicated vitamin C，s beneficial effect in chronic diseases like cardiovascular 
disease through its antioxidant mechanisms (Carr and Frei, 1999). In this in vivo 
study, vitamin C was applied as a positive control. According to the Recommended 
Dietary Allowances (RDAs) for U.S., the normal daily recommended intake for oral 
dosage of vitamin C for preventing deficiency was 50-60 mg per day for adult and 
teenage males. Assuming a normal male weighs 60 kg, the upper limit of the human 
dosage would be 1 mg/kg (60 mg/60 kg). The equivalent dosage for rats was 
calculated to be 6.2 mg/kg by multiplying the human dosage by 6.2 (1 mg/kg x 6.2 = 
6.2 mg/kg). It has been reported that vitamin C can preserve lipophilic antioxidants 
in LDL during oxidative modification (Jialal et al., 1990). 
Unlike the study of treatment efficacy of DG, the cardioprotective effect of DG was 
studied in normal Wistar rats. It is often stated that living tissues are under constant 
oxidative stress so that induction of oxidative damage may not be necessary. This is 
only true when the bio markers being tested are sensitive enough to be measured in 
low background levels of damage. Another criterion is the existing level of 
antioxidants in tissues and whether additional antioxidants is, due to limitation of 
absorption and excretion, accumulated to an extent which can significantly alter the 
antioxidant status of the tissues (Anderson and Phillips, 1999). 
The antioxidant/oxidant balance is perturbed in several pathologies and can be 
modified by diet or antioxidants supplement. The effect of antioxidant supplement 
53 
Chapter 3 In vivo Antioxidant Level 
can be evaluated by determining whether it can up-regulate the antioxidant levels 
with attenuating effect on the undesirable effect of increased oxidative stress (Llesuy 
et al., 2001). As a complete analysis of all the antioxidants is non-applicable, only 
the more important ones were taken into account, which included the plasma total 
antioxidant level, SOD, CAT, GPx and GST activities, and a-tocopherol and ascorbic 
acid content. 
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Fig 3.4 Effect of 12-week treatment on the body weight of the young rats. Mean 士 
S.E.M., n = 8. 
DG treatment did not affect the growth rate of the rats as there were no significant 
differences in body weights among the four groups at the end of the 12-week 
treatment (negative control: 0.729 士 0.030 kg; positive control: 0.736 ± 0.030 kg; Ix: 
0.726 士 0.028 kg; 3x: 0.717 士 0.030 kg) (Fig 3.4). 
Danshen is relatively nontoxic. Even a higher dosage can be tolerated in vivo. It was 
reported that the water extract of Danshen administered to rabbit intraperitoneally at 
a dose 2-3 g/kg/day for 14 days did not lead to any toxic signs (Huang, 1999). 
Intravenous injection of tanshinone IIA, an active component of Danshen, 
demonstrated that liver and gall bladder can trap the highest concentration of this 
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compound and 70% was excreted in the feces via bile and the remainder appeared in 
the urine (Huang, 1999). The toxicity of Gegen is also relatively low. Mice receiving 
the herb at 2 g/kg/day for 2 months showed no significant pathological abnormalities 
(Huang, 1999). This suggested that DG should be suitable for long-term 
administration, which is important for developing DG into any potential dietary 
supplement. 
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Fig 3.5 Effect of the 12-week treatment on the plasma total antioxidant level of the 
young rats. *P<0.05 by Mann-Whitney test. Mean 士 S.E.M., n = 8. 
The plasma total antioxidant level was evaluated by ABTS Radical Cation 
Decolorization Assay. As shown in Fig 3.5, in comparison with the negative control 
group, 3x DG treatment induced a significant increase of 111% 士 3o/o in the rat 
plasma total antioxidant level (P<0.05) at week 12. However, there was no 
significant change in the positive control and Ix groups of treatment from week 0 -
12. 
A variety of low molecular weight antioxidants in the plasma is important in the 
removal of ROS. Due to their different hydrophobicities, these antioxidants 
distributed at different cellular compartments. It is of great interest to determine their 
levels and whether they can be controlled by antioxidant-rich diet or antioxidant 
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supplement. The large number of different antioxidants in plasma means 
measurement of each antioxidant separately non-applicable. The possible interaction 
among different antioxidants in vivo also makes measurement of individual 
antioxidant less representative (Prior and Cao, 1999). To evaluate the capacity to get 
rid of ROS, the concentration of the overall concentration of this variety of 
antioxidants in plasma was determined. 
ABTS Radical Cation Decolorization Assay is a decolorization technique in which 
the stable radical is generated prior to the reaction with antioxidants. Reaction 
between ABTS and potassium persulfate produces blue/green ABTS-+. Addition of 
plasma reduces the free radical back to ABTS to an extent depending on the 
antioxidant activities, concentration of antioxidants and duration of the reaction. 
ABTS Radical Cation Decolorization Assay measures the antioxidant activities of the 
plasma antioxidants including ascorbic acid, a-tocopherol, uric acid, glutathione and 
flavonoids (Re et al., 1999), which includes the absorbed antioxidant content from 
DG It gives a parameter for comparing the total charge of the antioxidants present. 
Although the relative reactivity of different ROS toward a series of antioxidants 
varies, the parameter is still considered to be a useful indicator for the measurement 
of the system's ability to regulate ROS (Llesuy et al” 2001). 
In the assay, the absorbance was measured at 6 min sharp after the addition of plasma 
so that the percentage inhibition can be determined as a function of concentration. 
The duration time for reaction was based on the result of the effect of time on the 
suppression of absorbance (data not shown). The total level of antioxidant was 
expressed in terms of the equivalent concentration of Trolox as a standard. Trolox, a 
water-soluble compound with an active moiety similar to that of a-tocopherol, is a 
frequently used standard for water-soluble antioxidants. The capacity of the plasma 
to inhibit ABTS.+ at a defined time point relative to Trolox allows the comparison 
among the relative antioxidant activities from different treatment groups (Re et al, 
1999). 
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Plasma SOD Activity in the Young Rats 
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Fig 3.6 Effect of the 12-week treatment on the plasma SOD activity of the young rats. 
*P<0.05 by Mann-Whitney test. Mean 土 S.E.M., n = 8. 
Both the plasma SOD activity of the positive control group, Ix DG and 3x DG 
treatment group were higher than that of the negative control group in the young rats 
since week 4，and their plasma SOD activity reached about 120% after 12-week 
treatment. In the Ix DG treatment group, the plasma SOD increased from week 4 and 
raised significantly (^<0.05) to 120% 士 3o/o and 121% 士 S � / � i n week 8 and week 12, 
respectively. However, a remarkable increase (/7<0.05) o f 121o/o 士 5o/o in the plasma 
SOD activity in the 3x DG treatment group was only observed at week 12 while that 
of the positive control group attained 136% 士 1 lo/o at week 8 (/?<0.05). 
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Plasma CAT Activity in the Young Rats 
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Fig 3.7 Effect of the 12-week treatment on the plasma CAT activity of the young rats. 
*P<0.05 by Mann-Whitney test. Mean 士 S.E.M., n = 8. 
Both the plasma CAT activity of the positive control group, Ix DG and 3x DG 
treatment group were higher than that of the negative control group since week 4 in 
the young rats. Nevertheless, both Ix DG treatment and 3x DG treatment could give 
a steady increase in the plasma CAT activity since week 4 while positive control 
treatment could not. At week 8 and week 12, a significant increase (/7<0.05) in 
plasma CAT activities of the rats in Ix DG and 3x DG treatment group were shown, 
which were about 157% 士 25% and 168% 士 26%, respectively, at week 8, and 186% 
士 350/0 and 182% 士 33o/o, respectively, at week 12 of those in the negative control 
group. 
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Plasma GPx Activity in the Young Rats 
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Fig 3.8 Effect of the 12-week treatment on the plasma GPx activity of the young rats. 
*P<0.05; **/7<0.01 by Mann-Whitney test. Mean 士 S.E.M., n = 8. 
All the three treatment groups could produce a significant increase in the plasma GPx 
activity of the young rats measured at week 4, week 8 and week 12. Compared to the 
negative control group, the significant increase (p<0.01) of plasma GPx activity in all 
the three treatment groups seemed to attain maximum in week 4. 
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Plasma GST Activity in the Young Rats 
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Fig 3.9 Effect of the 12-week treatment on the plasma GST activity of the young rats. 
Mean 士 S.E.M., n = 8. 
Comparing the above results, there was no significant change in all the treatment 
groups for the plasma GST activity in the young rats throughout the 12-week 
treatment. 
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Fig 3.10 An example of HPLC chromatogram of plasma a-tocopherol. 
Plasma a-tocopherol Content in the Young Rats 
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Fig 3.11 Effect of the 12-week treatment on the plasma a-tocopherol content of the 
young rats. */^<0.05 by Mann-Whitney test. Mean 士 S.E.M., n 二 8. 
The plasma content of a-tocopherol was measured by HPLC. With the flow rate at 1 
ml/min, the retention time of 5-tocopherol was about 10.7 min and that of a-
tocopherol was about 15 min. After the 12-week treatment, Ix and 3x DG treatment 
resulted in a significant increase in the plasma a-tocopherol content at week 12. 
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When the young rats were treated with Ix DG, a steady increase in the plasma a-
tocopherol content was observed from week 4 to week 8. Their plasma a-tocopherol 
content further increased significantly (/><0.05) to 125% 土 15% at week 12. On the 
other hand, no significant change was measured in the plasma a-tocopherol content 
of 3x DG group until week 12, at which the level raised to about 115% 士 8o/o 
(p<0.05). No remarkable increase was found in the positive control group in the 
plasma a-tocopherol content. Therefore, Ix DG treatment seemed to increase the 
plasma a-tocopherol content the most in the young rats. 
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Plasma Ascorbic Acid Content in the Young Rats 
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Fig 3.13 Effect of the 12-week treatment on the plasma ascorbic acid content of the 
young rats. Mean 土 S.E.M., n = 8. 
With the flow rate at 1 ml/min, the retention time of AA was about 7 min. Similar to 
the plasma GST activity of the young rats evaluated previously, there was no 
significant effect found in all the treatment groups for the plasma ascorbic acid 
content. 
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Unlike human, rat is not a vitamin C-dependent species (Aprikian et al., 2001). The 
ability of the rats to synthesize ascorbic acid requires an enzyme L-gulono-lactone 
oxidase (GLO) which resides in the liver of the mammals, but is absent in the guinea 
pig, the flying mammals, monkey, and man. It can only be concluded that DG has 
little effect on the enzyme GLO. Unexpectedly, the positive control group did not 
show significant changes in the plasma ascorbic acid content neither. At biological 
pH, ascorbic acid (AA) is the main form of vitamin C, but AA can be rapidly 
oxidized to dehydroascorbate (DHAA) and depleted in extra cellular biological fluid 
(Halliwell et al., 1992). The oxidation in plasma can be influenced by sample 
concentration, temperature, light, pH, dissolved oxygen, solvent, ionic strength, and 
the presence of ferric ions or oxidizing enzymes (Cooke and Moxon, 1981; Koshiishi 
et al., 1998). The significance of AA and DHAA to work as an antioxidant couple in 
biological systems are widely reported. The HPLC method used in present study 
focused on AA whereas the response of the UV detector to DHAA was low (Karlsen 
et al., 2005). Thus, this may underestimate the antioxidant power from all forms of 
plasma vitamin C. 
In a study for normal human volunteers (Anderson and Phillips, 1999)，the 
administration of 60 mg vitamin C/day also showed little effect on plasma vitamin C 
levels in spite of the evidence of the protective effect against lipid peroxidation and 
the 10% increase in the total antioxidant capacity of the plasma. It was suggested that 
a more remarkable results may be found by studying human populations relatively 
deficient in vitamin C as the volunteers drawn were well-nourished ones who gained 
adequate dietary intake of the vitamin. 
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Lipid Peroxidation in the Young Rats 
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Fig 3.14 Effect of the 12-week treatment on the MDA concentration of liver 
homogenate in the young rats. Mean 土 S.E.M., n = 8. 
Comparing the above results, there was no significant change in all the treatment 
groups for the lipid peroxidation level, expressed in terms of MDA concentration in 
the liver, in the young rats after the 12-week treatment. 
The present result showed that all the treatments have no obvious effect on GST 
activity (Fig 3.9) and level of lipid peroxidation (Fig 3.14). This violates with some 
finding that revealed vitamin C can decrease the level of TBARS and increase GST 
activity in different tissues of rabbits (El-Demerdash et al., 2005). However, most of 
those studies involved the usage of toxic substances such as stannous chloride (SnCb) 
to induce oxidative stress in the control group. Thus, the GST activity was decreased 
and lipid peroxidation was induced in control group so that the basal level for 
comparison was different. Also, tissue GST activity may differ from plasma GST 
activity as measured in the present study. 
It should be noted that the elevation of some of the antioxidant levels during DG 
treatment was unable to raise the total antioxidant level significantly at week 4 and 8 
(Fig 3.5). This may be due to the small contribution of the antioxidant enzymes to the 
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measurement of colour suppression in the ABTS assay. The ABTS assay measures 
mainly the low molecular weight antioxidants such as GSH and polyphenols in 
plasma while the actions of antioxidative enzymes are rather specific targeting 
unique substrates. 
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Fig 3.15 (a) Protein expression of SOD in the liver of the young rats. (3-actin was 
used as the loading control, (b) The relative quantity of the sample to control. 
*/^<0.05. Mean 士 S.E.M. Results are representative of four independent experiments. 
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Fig 3.16 (a) Protein expression of SOD in the heart of the young rats. GAPDH was 
used as the loading control, (b) The relative quantity of the sample to control. 
*P<0.05. Mean 士 S.E.M. Results are representative of four independent experiments. 
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Fig 3.17 (a) Protein expression of CAT in the brain of the young rats. (3-actin was 
used as the loading control, (b) The relative quantity of the sample to control. 
*P<0.05. Mean 士 S.E.M. Results are representative of four independent experiments. 
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Fig 3.18 (a) Protein expression of CAT in the heart of the young rats. GAPDH was 
used as the loading control, (b) The relative quantity of the sample to control. 
*P<0.05. Mean 士 S.E.M. Results are representative of four independent experiments. 
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Fig 3.19 (a) Protein expression of GPx in the liver of the young rats. P-actin was 
used as the loading control, (b) The relative quantity of the sample to control. 
*P<0.05. Mean 士 S.E.M. Results are representative of four independent experiments. 
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Besides the plasma antioxidant activities, the enzymes protein expressions in the 
organs, liver, heart and brain, were evaluated. These results reflected the antioxidant 
protection of organs against oxidative stress. The SOD expression in liver and heart 
was up-regulated in all the 3 treatment groups. In addition, a more obvious increase 
was found in DG treatment group than in the positive control group. CAT expression 
in brain and heart was induced by vitamin C treatment and DG treatment. A more 
obvious increase of CAT in brain was also found in DG treatment group than that in 
the positive control group. Also, GPx expression in liver was also increased by 
vitamin C and DG treatment. This indicates that the protection effect of DG can be 
directed to hepatocytes, cardiomyocytes and brain cells. 
How can DG up-regulate the endogenous antioxidants? 
Traditional Chinese physicians prescribed Danshen to stabilize the heart and calm 
nerves, "lighten" blood, and remove "stagnant" blood. Modern uses include the 
treatment of angina, cerebral atherosclerosis, diffusive intravascular clotting, and 
thrombophlebitis (Huang, 1999). Danshen contains several ketone and alcohol 
derivatives including tanshinone (I, IIA and IIB), cryptotanshinone, 
isocryptotanshinone, miltirone, tanshinol (I and II), and salviol (Zhu et al., 2004). 
Aqueous constituents of Gegen include daidzein, daidzin, puerarin, 5-
hydroxypuerarin, 3'-hydroxypuerarin and 3'-methoxypuerarin (Jiang et al., 2005). 
The chemical profile of the water extract of DG has shown that the formulation was 
rich in polyphenols (Fig 3.20) (Chan, 2006). 
69 
Chapter 3 In vivo Antioxidant Level 
120 I — 
Det 168-280nm 
— D S Y G 7 : 3 H 2 0 extract 
DSYG7to36-7-2005 5-58-41 PM.dat Rcicniion Tinie 
100 藏 Area f. ： I 5 IN n •c 80 I m a {A 
• 乂. 卜. rj X 
60 . i % E ？: U I s 40 j I I I 5 3 与 -§ £ -e 20 fe. s •a J p j 二 \ 0 ^ _ r > LAJIU^ J A _ _ 
0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 30.0 32.5 35.0 37.5 40.0 42.5 45.0 
Minutes 
Fig 3.20 HPLC chromatogram of DG water extract. (Chan, 2006) 
The therapeutic effect of these phenolic compounds generally related to the actual 
bioavailability rather than dose administered (Keung et al,, 1996). Low molecular 
weight polyphenolics could be absorbed to a larger extent than high molecular 
weight ones (Aprikian et al, 2001). But crude drugs are thought to be less toxic and 
have higher bioavailability. It was shown that daidzin administered as crude Gegen 
extract has a higher rate and even higher extent of availability than pure synthetic 
daidzin (Keung et al, 1996). The extract of Gegen was capable to enhance the 
solubility of daidzin in PBS and the bioavailability/uptake of its own active 
components (Keung et al., 1996). Among the glycosides of Gegen, puerarin is the 
most potent one. Puerarin, given orally to volunteers, was completely absorbed from 
the intestine. After absorption, it was bound (42%) to plasma albumin. It was 
distributed mainly in the liver and kidney, and less extensively in the brain. It was 
eliminated mainly by metabolism in the liver; only 10% of the absorbed dose was 
excreted in the urine in the unchanged form. Crude drugs are believed to be less toxic 
and have higher bioavailability than pure synthetic ones (Keung et al., 1996). The 
bioavailability of DG may be reflected by the increased plasma antioxidant level 
measured by ABTS assay (Fig 3.5). 
DG administration can up-regulate the antioxidant system and provide protective 
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effect to normal animals against sudden imbalance between ROS level and 
antioxidant level. Healthy cells can scavenge free radicals effectively by their 
endogenous antioxidants and maintain a dynamic relationship between ROS and 
antioxidants in the body. However, in some pathological conditions, e.g. cells 
suffering ischaemic insult, the sudden generation of ROS can upset this balance. 
Natural antioxidants including SOD, CAT and GPx may then be depleted resulting in 
accumulation of ROS. DG extract was rich in polyphenols which are a group of the 
chemical substances found in plants, characterized by the presence of more than one 
phenol group per molecule. Flavonoids are a group of polyphenols which are 
commonly known for their antioxidant activity. In such situation, antioxidants from 
DG can play an important protective role by enhancing the activity of original natural 
antioxidants and/or neutralize ROS by non-enzymatic mechanisms (Zhu et al., 2004) 
to prevent further progress of the oxidant-relative disorder. 
Different active components of DG have been shown to possess antioxidant activities. 
Danshensu, an important compound in Danshen, is a preventive antioxidant which 
could scavenge superoxide anions generated from the xanthine-xanthine oxidase 
system and thus protect the myocardial mitochondrial membranes from lipid 
peroxidation. Being more hydrophobic, tanshinone could scavenge lipid free radicals 
at the site where they are produced due to easier entry (Zhao et al., 1996). Thus, 
tanshinone could serve as a chain-breaking antioxidant. Danshen has also been 
reported to up-regulate or recover antioxidant level in disease condition as higher 
activities of antioxidant enzymes such as SOD, CAT, GPx, and GST was found in the 
liver of rats with acute MI, associated with lower myocardial and hepatic TBARS 
values (Ji et al., 2003). In a recent study, ischaemic animals treated with Danshen 
extract also showed increased activities of SOD (Zhu et al., 2004). On the other hand, 
Gegen can improve coronary circulation and lower myocardial oxygen consumption. 
It was shown to lower blood pressure and heart rate in the spontaneously 
hypertensive rat (SHR), but has little or no effect on normal Wistar rats (Huang, 
1999). The glycosides can cause muscular relaxation and decrease in heart rate. It 
was reported that puerarin, the main isoflavone of Gegen, acts as an enzymatic 
inhibitor of the oxygen radical production mediated rather than a true antioxidant 
(Guerra et al., 2000). However, the Gegen crude extract exhibited antioxidant kinetic 
similar to that ofTrolox (Speroni et al., 1996). 
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Apart from inducing or recovering the antioxidant level in diseased animals, the 
present study has shown DG could also up-regulate the basal antioxidant system in 
normal Wistar rats. Plasma SOD, CAT and GPx activities, as well as the protein 
expression in organs, were shown to have a significant increase (p<0.05) under the 
DG treatment (Fig 3.6-3.8; 3.15-3.19). Thus, it provides better protection against 
CVD. 
Apart from up-regulating the enzymatic antioxidants, DG treatment also increased 
the plasma a-tocopherol content (Fig 3.11). Among the different iso forms of vitamin 
E, a-tocopherol is preferentially retained by the body and is the strongest antioxidant 
in the vitamin E family (Jiang and Ames, 2003). Although it was claimed that 
Danshen contains a small amount of vitamin E (Huang, 1999), there was no 
detectable vitamin E by HPLC in the Danshen 20% ethanol extract (Wu et al., 1998). 
The increase in the plasma a-tocopherol should not be due to the vitamin E content 
in the DG extract but the antioxidant activity of the extract. 
The antioxidants content of the DG may also scavenge free radicals and indirectly 
protect LDLs from oxidative modification, and thus sparing the vitamin E in LDL. It 
was found that LDLs from Danshen treated animals contain more vitamin E and 
were more resistant to oxidation ex vivo (Wu et al., 1998). The DG treatment could 
preserve vitamin E in LDL particles and resist LDL oxidation in the sub-endothelial 
space. 
Many of the active components have been purified and studied for their antioxidative 
properties, e.g. SAB, danshensu and tanshinone. Their antioxidative activities may be 
due to the chemical structure. They possess unsaturated rings (Fig 3.21) which are 
common features in antioxidants, e.g. vitamin E (Fig 3.22). A component of Danshen, 
the water-soluble tanshinone derivative, was shown to have similar bio active effect 
as the reference antioxidant Trolox. Its endothelium protection effect is important as 
the endothelium is recognized to be a major site of oxidant generation and attack. 
The derivative protects the human endothelial cells against oxyradical damage 
generated by the xanthine oxidase and hypo xanthine in vitro (Wu et al., 1993). The 
high water solubility of the tanshinone derivative makes it a more active radical 
scavenger for the endothelial cells than its less water-soluble forms. It may also be 
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capable in inhibiting oxyradical formation such as in leukocytes and impaired 
mitochondria (Wu et al., 1993). The DG extract was rich in polyphenols which are 
more hydrophilic than a-tocopherol. They might be localized near the membrane 
surface scavenging aqueous radicals and thus prevent the consumption of tocopherol 
(Sanchez-Moreno et al., 2000). 
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Fig 3.21 Chemical structure of some of the major active constituents of Danshen. 
(Zhu et al” 2004; Adams et al., 2006) 
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Fig 3.22 Chemical structure of a-tocopherol (vitamin E). 
Vitamin E is the most effective lipid-soluble chain-breaking antioxidant in cell 
membrane. It can stabilize the membrane and protect against oxidative stress induced 
by reducing lipid peroxidation. In addition, the increase in vitamin E is thought to be 
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able to maintain endothelial function by scavenging the free radicals in the 
bloodstream so as to reduce their direct injury to endothelium. It also reduces lipid 
peroxidation induced by exogenous ROS such as smoking (Helen et al., 2003). The 
ability for a-tocopherol to reduce endothelial dysfunction was shown by it reducing 
some endothelial markers (Haidara et al., 2004). 
Oxidative and reductive decomposition of lipid peroxides mediated by heme-proteins 
or transition metal ions can amplify the peroxidation process. The mode of oxidation 
inhibition of polyphenols was unclear but possibly by chelating metal ions; 
scavenging lipid alkoxyl and peroxyl radicals by acting as chain-breaking 
antioxidants or hydrogen donors; and/or regenerating a-tocopherol by reducing a-
tocopheroxyl radical (Sanchez-Moreno et al, 2000). 
Some studies also suggested that antioxidants such as polyphenols in plant water 
extracts can enhance phase II enzymes by up-regulating the corresponding gene 
transcription by interaction with antioxidant response element (ARBs) in their 
promoters (Ferguson, 2001). Thus, polyphenols content in DG may also interact with 
AREs in vivo and transcriptionally regulate the genes although more work may still 
be needed on the determination of mRNA level in tissues. 
3.2 DG Effect on in vivo Antioxidant Levels on Middle-aged Wistar Rats 
Advanced age is an important high risk factor for CVD. One of the reasons for 
advance-aged persons being more likely to develop CVD may be the consequence of 
diminished antioxidant protection (Hagihara et al., 1984). 
Similar approach as described in section 3.1 was repeated on normal middle-aged 
male Wistar rats. 
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3.2.1 Materials and Methods 
Danshen-Gegen was applied intra-gastrically to the normal middle-aged male Wistar 
rats (10-month-old) for twelve weeks. The rats were divided into two groups: 1) 
negative control: water; and 2) 3x: 0.9 g/kg of DG. Each four weeks, plasma was 
collected to monitor the levels of the major antioxidants and ROS detoxification 
enzymes. After twelve weeks, all rats were killed and the livers were isolated for 
determining the level of lipid peroxidation. The materials and methods involved were 
same as those described in section 3.1.1. 
3.2.2 Results and Discussion 
In this part of in vivo study, the results obtained using middle-aged rats model were 
comparable to those described in the previous section using young rats model. 
Moreover, obvious lipid peroxidation inhibition by DG treatment can be seen. 
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Fig 3.23 Effect of 12-week treatment on the body weight of the middle-aged rats. 
Mean 士 S.E.M., n = 8. 
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The weights of the middle-aged rats in both negative control group and 3x DG group 
were similar and were stable over the 12-week treatment, which kept at around 0.7 
kg. 
Total Antioxidant Level in the Middle-aged Rats 
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Fig 3.24 Effect of the 12-week treatment on the plasma antioxidant level of the 
middle-aged rats. **P<0.01 by Mann-Whitney test. Mean 士 S.E.M., n = 8. 
The plasma total antioxidant level in the middle-aged rats only significantly 
increased (/KO.Ol) to 113% 土 2o/o when they were treated with 3x DG for 12 weeks. 
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Plasma SOD Activity in the Middle-aged Rats 
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Fig 3.25 Effect of the 12-week treatment on the plasma SOD activity of the middle-
aged rats. Mean 士 S.E.M., n = 8. 
The SOD plasma activity in the middle-aged rats in 3x DG treatment group increased 
gradually from week 4 to week 12. However, this increase was marginally 
insignificant. 
77 
Chapter 3 In vivo Antioxidant Level 
Plasma CAT Activity in the Middle-aged Rats 
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Fig 3.26 Effect of the 12-week treatment on the plasma CAT activity of the middle-
aged rats. *P<0.05 by Mann-Whitney test. Mean 士 S.E.M., n = 8. 
The plasma CAT activity in the middle-aged rats in 3x DG group was higher than 
that in negative control group and it increased steadily up to about 183% 士 32o/o of 
that in control group at week 12 (p<0.05). 
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Plasma SOD Activity in the Middle-aged Rats 
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Fig 3.27 Effect of the 12-week treatment on the plasma GPx activity of the middle-
aged rats. *P<0.05 by Mann-Whitney test. Mean 士 S.E.M., n = 8. 
The plasma GPx activity in the middle-aged rats in 3x DG treatment group was 
higher than that in negative control group in all the time intervals measured. 
Moreover, after treating with 3x DG for 8 weeks and 12 weeks, the plasma GPx 
activities increased significantly (p<0.05) to 114% 士 5o/o and 119% 士 2o/o, 
respectively. 
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Plasma SOD Activity in the Middle-aged Rats 
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Fig 3.28 Effect of the 12-week treatment on the plasma GST activity of the middle-
aged rats. Mean 士 S.E.M., n = 8. 
There was no significant difference in the plasma GST activity between rats in the 
negative control group and 3x DG treatment group throughout the 12-week treatment. 
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Plasma a-tocopherol Content in the Middle-aged Rats 
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Fig 3.29 Effect of the 12-week treatment on the plasma a-tocopherol content of the 
middle-aged rats. *P<0.05; **p<0.01 by Mann-Whitney test. Mean 士 S.E.M, n = 8. 
There was no significant difference in the plasma a-tocopherol content between the 
rats in negative control group and 3x DG treatment group from week 0 to week 4. 
However, the plasma a-tocopherol content in 3x DG treatment group increased 
significantly (p<0.01) to 147% 士 I S � / � a t week 8 and further increased (p<0.05) to 
158% ± 16% at week 12. 
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Plasma Ascorbic Acid Content in the Middle-aged Rats 
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Fig 3.30 Effect of the 12-week treatment on the plasma ascorbic acid content of the 
middle-aged rats. Mean 士 S.E.M, n = 8. 
Comparing the results of plasma ascorbic acid described above, no significant 
change was observed when the middle-aged rats was fed with 3x DG throughout the 
time intervals tested. 
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Lipid Peroxidation in the Middle-aged Rats 
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Fig 3.31 Effect of the 12-week treatment on the MDA concentration of liver 
homogenate in the middle-aged rats. *P<0.05 by Mann-Whitney test. Mean 士 S.E.M., 
n = 8. 
The effect of DG treatment on the lipid peroxidation in the middle-aged rats was 
evaluated and the results revealed that lipid peroxidation in the middle-aged rats 
treated with 3x DG was reduced. The MDA concentration per gram protein 
decreased obviously (/?<0.05) from 364 士 27.1 |iM to 304 士 16.5 |iM, which 
accounted for about 60 [iM reduction. 
The consequences of DG treatment on antioxidant protection was evaluated by 
determining MDA in liver homogenate, which can reflect the extent of lipid 
peroxidation in the body and thus the capacity of antioxidant system to protect 
against peroxidative attacks. 
Thiobarbituric Acid Reacting Substances (TBARS) are the secondary products of 
lipid peroxidation. These secondary products are mainly aldehydes and the major 
compound is malondialdehyde (MDA) (Zhu et al., 2004). MDA is the end product of 
non-enzymatic degradation of PUFA. While increased plasma MDA has been shown 
to associate with hypertension (Kashyap et al., 2005), lower MDA level indicates 
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decreased intensity of lipid peroxidation. Lower level of free radicals and lipid 
peroxides can maintain and restore cell membrane integrity, and thus limits cellular 
injury. 
Although only certain lipid peroxidation products would give rise to MDA, and it is 
not a single exclusive end-product generated in lipid peroxidation, and TEARS assay 
is intrinsically non-specific for MDA, MDA analysis can offer a global determination 
on the complex process of the fatty peroxides formation. The interpretation of results 
requires the utilization of correlative data from other indices of oxidative stress 
(Aprikian et al., 2001), for example the total antioxidant level, the enzymatic and 
non-enzymatic antioxidants content/activity. 
DG treatment on aged rats led to a significant decrease in MDA level (Fig 3.31) 
which was not observed in the same treatment on young rats (Fig 3.14). It may be 
due to a higher basal level of lipid peroxidation in the aged rats as it was reported 
that level of lipid peroxidation increases with age in normotensive rats (Kashyap et 
al” 2005). With a higher basal value, the suppressive effect on lipid peroxidation of 
DG can be observed in the aged rats. Lower liver MDA level suggested lower 
intensity of lipid peroxidation and reflected an improved antioxidant status in the rats 
fed with DG. Salvia miltiorrhiza significantly inhibited lipid peroxidation in an in 
vivo study in the acute phase of acute MI in animals (Zhu et al., 2004). 
Lower MDA availability should also limit the opportunity for MDA-modified HDL 
formation, which is a less effective precursor for biliary cholesterol secretion and bile 
acids transformation with less cholesterol secretion (Guertin et al., 1994). MDA-
modifled HDL also caused an enhanced accumulation of cholesterol in the liver and 
the kidneys in vivo. It seems to impair the tissue distribution of its cholesterol moiety, 
particularly in the liver, where it accumulates at the expense of bile acid 
transformation (Guertin et al., 1994). This supported that DG exhibits cholesterol-
lowering effect with anti-atheromatous significance. 
MDA was also found negatively correlated with SOD (Kashyap et aL, 2005). 
Although the increase in SOD activity in the present study was marginally 
insignificant, it showed a steady increasing trend and it may be expected that SOD 
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activity would show a significant increase for longer treatment time. And the 
correlation between MDA and SOD would still be shown in the present study. 
Impact of ageing on CVD 
Most of the approaches to study the impact of ageing on CVD have been performed 
in the rats on the basis that the modifications to their cardiovascular system are 
comparable to the effect of cardiovascular ageing in human (Tanguy et al., 2003). In 
generally, the normal life span of male Wistar rats is about 30-36 months. Thus, 4-
month-old rats can be considered as adults or mature rats, 16-month-old rats are 
older adults or old rats, and 24-month-old rats are senescent rats (Folkow and 
Svanborg, 1993). 
Ageing appears to be associated with an increase in incidence and a worsening of 
consequences of CVD (Yang et al., 1987). Different mechanisms have been proposed 
to explain this age-related degeneration such as an increase in endothelin production, 
higher calcium overload, reduced ROS scavenging and/or increased ROS production 
(Besse et al., 2001; Xia et al” 1995). Therefore, up-regulating the antioxidants level 
in the older animals can compensate for the impairment of ROS elimination system, 
help ROS scavenging and reduce ROS production, thus provide better protection 
against CVD. 
Overproduction of ROS leading to an overwhelming of the endogenous defenses 
against these species has been shown in aged rats (Farber, 1994). Advanced age has 
been shown to be associated with higher cholesterol levels. Age-associated 
vulnerability to ischemia-reperfusion has been reported. An ex vivo study showed 
that the senescent heart was less tolerant to low-flow ischemia and to reperftision 
injury than adult heart (Besse et al., 2006). Cardiac GPx is one of the major systems 
involved in elimination of ROS in myocytes (Molina and Garcia, 1997). With the 
observation that selenium status decreases with age in human (Savarino et al., 2001), 
which is a key component in the seleno-dependent form of GPx, a decreased ability 
to eliminate ROS is associated with ageing. Reinforcing cardiac GPx can reduce the 
susceptibility of old rats heart to ischaemia and reperftision (Tanguy et al., 2003). 
Lower CAT activity has been shown in myocardium of old rats than in young-adults 
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(Boucher et al., 1998). This also suggests a reduced ability for old rat heart to 
eliminate hydrogen peroxides. In addition, a clinical study has revealed that in 
elevated-oxidative-stress subjects, depleted ascorbic acid levels were detected. 
Healthy adults at age 29 士 10 had the mean plasma AA at 63.7 士 18.9 |imol/L while 
adults at age 55 士 9, with smoking, elevated blood pressure or high cholesterol 
inclusive, had 47.3 士 15.4 |imol/L (Karlsen et al,, 2005). Moreover, cellular ageing 
was characterized by an increased cytosolic density that would lead to an overall 
basis of decrease in the cellular enzymes that involved in ROS scavenging (van der 
Sanden et al., 1995). Thus, several reports suggested that the consumption of dietary 
antioxidants or antioxidants supplement has a protective role against degenerative 
diseases of ageing, including cardiovascular disease. 
Drug metabolizing systems are compromised in elderly patients. The contribution of 
age to altered drug metabolism in the elderly is difficult to assess because drug 
interactions, types of drugs taken at a time, underlying disease and increased inter-
individual variability contribute to the ageing process. After decades of research into 
the matter, a general aphorism "start lower - go slower" is valid more than ever in 
geriatric prescribing. A possible explanation may be the age-related changes in 
hepatic structure and fiinction, although liver function seems to be quite well 
maintained in old age (Zeeh and Piatt, 2002). Thus, it is important for DG to produce 
the same cardio-protective effect in older animals, which are expected to possess a 
higher risk for CVD, as in the younger ones, and at the same time is well-tolerated 
causing little undesirable effect in long term administration. 
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3.3 Summary 
Young rats Middle-aged rats 
VitC Ix ^ ^ 
Total 
antioxidant / / •111% ±3% **113o/o 士 2o/o 
level 
SOD *136%± 1 1 % * 1 2 1 % ± 5 % * 1 2 1 % ± 5 % 121% ±9% 
CAT * 159% ± 3 6 % • 1 8 6 % ± 3 5 % * 1 8 2 % ± 3 3 % •183% ± 3 2 % ^ 
G?x *146%± 1 2 % * * 1 2 6 % ± 7% **135% ± 6% *119%±2% 
G^ / 1 / 1 
a-tocopherol 1 *125%± 1 5 % * 1 1 5 % ± 8 % *158%± 16% 
Ascorbic acid I I I / 
*|60 |iM 
[MDA] / / / (per gram protein) 
Table 3.2 Summary on the DG effect on antioxidant status in vivo (the maximum 
changes compared to the negative control group during the 12-week treatment are 
listed). *P<0.05; **/7<0.01 by Mann-Whitney test. Mean 士 S.E.M. 
Antioxidants may ameliorate endothelial dysfunction that contributes to oxidative 
stress and plays a major role in the initial stage of atherosclerosis (Haidara et al., 
2004). There is growing interest in replacing synthetic antioxidants with natural 
ingredients because of the concern over the possible carcinogenic effects of synthetic 
antioxidants in foods (Shahidi, 2000). In this study, long term treatment (12-week) of 
low dose and high dose DG did not cause any pathological abnormality in both the 
young and middle-aged rats. Together with other reports studying the toxicity of 
Danshen and Gegen, crude extract of DG is well-tolerated and is suitable to serve as 
a dietary supplement as little adverse effect was found. 
Certain highly reactive oxidant species for example OH- and peroxynitrite are 
cytotoxic. The expression of antioxidant enzymes such as SOD, CAT and GPx, and 
non-enzymatic antioxidants such as vitamin E play an important role in determining 
the amount and species of ROS, and are also critical in regulating the response of a 
cell to ROS production (Irani, 2000). DG is rich in antioxidants such as polyphenols. 
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DG treatment not only increased plasma antioxidant capacity by absorption of its 
content, but was also able to boost the endogenous antioxidant level in plasma and 
tissues. In addition, DG also up-regulated the protein expression of the antioxidant 
enzymes in organs like liver, heart and brain (Fig 3.15-19). In such aspect, DG 
treatment may serve as a potential dietary antioxidant supplement for the prevention 
of CVD. DG may even be a better antioxidant supplement than vitamin E or C 
because polyphenols, in general, are better antioxidants than other common 
antioxidants such as vitamin E or C, as they showed higher efficiency in the 
inhibition of LDL oxidation (Smichez-Moreno et al., 2000). Also, in the present study, 
DG showed a better antioxidative effect than vitamin C as evidenced by the finding 
that the positive control group (vitamin C treatment) failed to up-regulate the plasma 
total antioxidant level and a-tocopherol level significantly while the DG treatment 
could play the role (Table 3.2). Although Ix and 3x DG treatment gave similar 
consequence on the plasma antioxidants level, the cardio-protective effect of DG 
may not be dose-dependent. The SOD activity and a-tocopherol level in Ix group 
was higher than that in the 3x group (Table 3.2). 
Comparing the response of DG on young rats with the middle-aged rats, the older 
rats seem to give a slower response to the DG effect. For example, the CAT activity 
showed a significant increase at week 8 in the young rats (Fig 3.7) but such response 
was observed at week 12 in the older rats (Fig 3.26). Also, the GPx activity reached 
maximum at week 4 in young rats (Fig 3.8) whereas it increased steadily in the older 
rats (Fig 3.27). This agrees with the general finding that drug effect in older animals 
'start lower - go slower' as stated in the previous section (section 3.2.2). A possible 
explanation may be the altered efficiency of drug metabolism. Thus, to attain the 
cardio-protective effect, older persons may need a longer administration period for 
DG 
A significant inhibition of lipid peroxidation by DG treatment could only be shown 
in the middle-aged rats. This may be due to a higher level of oxidative stress in older 
rats. Also, older animals have diminished antioxidant protection and are more likely 
to develop CVD. Thus, DG can significantly reduce a high basal level of lipid 
peroxidation in middle-aged rats while the same effect on the young rats which have 
lower basal level of lipid peroxidation could not be seen. However, young rats gave 
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faster response than the older ones. Therefore, apart from using older ones, the young 
animals may be challenged with induced oxidative stress, e.g. homocysteine (Chan et 
al., 2004) so that the antioxidative effect of DG may be more evident. Other animal 
models (e.g. high-fat diet) with better endpoints (e.g. plaque formation and blood 
pressure) may be introduced in order to demonstrate the physiological effect of DG. 
Apart from the cholesterol-lowering and vasodilative effect, the anti-atherosclerotic 
effects of DG rely very much on its antioxidant activities. DG may potentially be 
beneficial in preventing CVD and protecting the stability of the genome against 
oxidative stress. 
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4.1 Conclusion 
Aqueous extract of DG can modulate the progress of early stage atherosclerosis by 
inhibiting foam cells formation by lowering lipid loading in macrophages and its 
antioxidative properties. It can also up-regulate the antioxidant system in vivo to 
attenuate oxidative stress so as to provide better protection against CVD. Such 
protective effect may be more obvious in middle-aged rats that have a higher basal 
level of oxidative stress and thus the risk of developing CVD but compromised drug 
metabolizing system. However, longer treatment time may be needed for older 
animals. Also, the low toxicity of DG allows long term administration. Apart from 
the treatment of CVD, DG may also be a potential dietary supplement to prevent 
development of CVD. 
4.2 Future Work 
As stated in section 2.2，the mechanism for DG to inhibit foam cells formation is still 
unclear. Further studies are needed to demonstrate the underlying molecules or 
pathways. A possible target may be the enzyme ACAT which catalyzes the 
conversion of free cholesterol to cholesteryl esters in macrophages. Also, more works 
are still required to investigate the effect of DG on the cholesterol efflux mechanism, 
such as the ABCAl transporter expression. 
Recently, more studies focus on the role of immune system on the development of 
atherosclerosis. Early stage of atherosclerosis progression consists of monocyte-
derived macrophages, shown by their contribution to foam cells and plaques 
formation. It was found that unstable plaques are particularly rich in activated 
immune cells indicating that they may play a role in initiating plaque activation. 
Based on the understanding of the mechanisms that govern the recruitment, 
differentiation, and activation of immune cells in atherosclerosis, some experimental 
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researches have identified several candidate antigens, and there are encouraging data 
suggesting that immune modulation as well as immunization may suppress the action 
of macrophages to reduce atherosclerotic plaques development and thus reduce the 
progression of the disease (Hansson, 2001). 
T-cells and cytokines play a critical role in regulating macrophage uptake of 
modified lipoproteins by scavenger receptor-A (SR-A) in atherosclerosis (Geng and 
Hansson, 1992). Components of oxLDL may be degraded or processed for antigen 
presentation to T-cells and also may activate the macrophage itself. This also results 
in T-cell activation, with proliferation and cytokine secretion (Hansson, 2001). 
Importantly, all these activities may be important in atherogenesis. It is of great 
interest to investigate the immunomodulation effect of DG on atherosclerosis 
prevention. 
CD4 
A r f ^ ^ 
MPh 
Fig 4.1 Antigen presentation of modified lipoproteins. oxLDL can be transformed 
into an auto antigen. Uptake by scavenger receptors (SR) is followed by intracellular 
processing in macrophages (MPh) and presentation of peptide fragments on MHC 
class II molecules (MHC-II). T-cell that carry the appropriate antigen receptors (TCR) 
and is in contact to the MHC-II:peptide complex in the presence of costimulatory 
factors (co-stim) such as CD4 are activated. This results in T-cell activation. 
(Hansson, 2001) 
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